{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "15",
                "@timestamp": "2023-07-15T08:17:22.000022-04:00",
                "@year": "2023",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2021",
                "@month": "11"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "AstraZeneca",
                "xocs:funding-agency": "AstraZeneca",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004325",
                "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
            },
            "xocs:funding-addon-generated-timestamp": "2021-12-09T23:51:02.276Z",
            "xocs:funding-text": "Editorial support was provided by S Gupta and G Toh from Tech Observer Asia Pacific.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60012718",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Cardiology"},
                                {"$": "Department of Medicine"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60012718",
                                "@dptid": "113122172"
                            },
                            "@affiliation-instance-id": "2015851048-16045e50c995edca45ce96b413851838",
                            "ce:source-text": "Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "113122172"
                        },
                        "author": [{
                            "ce:given-name": "Rungroj",
                            "preferred-name": {
                                "ce:given-name": "Rungroj",
                                "ce:initials": "R.",
                                "ce:surname": "Krittayaphong",
                                "ce:indexed-name": "Krittayaphong R."
                            },
                            "@author-instance-id": "2015851048-bbc735615ee2639248d6d276e682864e",
                            "@seq": "1",
                            "ce:initials": "R.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Krittayaphong",
                            "@auid": "7004257129",
                            "ce:indexed-name": "Krittayaphong R."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60006964",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Nephrology"},
                                {"$": "Department of Medicine"},
                                {"$": "Phramongkutklao Hospital and College of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60006964",
                                "@dptid": "112584168"
                            },
                            "@affiliation-instance-id": "2015851048-e32d3a396ff676ebd35806a97049adab",
                            "ce:source-text": "Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand",
                            "@dptid": "112584168"
                        },
                        "author": [{
                            "ce:given-name": "Bancha",
                            "preferred-name": {
                                "ce:given-name": "Bancha",
                                "ce:initials": "B.",
                                "ce:surname": "Satirapoj",
                                "ce:indexed-name": "Satirapoj B."
                            },
                            "@author-instance-id": "2015851048-3f328dbc8892eeb0cb3139191b2e9986",
                            "@seq": "2",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Satirapoj",
                            "@auid": "14632290200",
                            "ce:indexed-name": "Satirapoj B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60012718",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Endocrinology"},
                                {"$": "Department of Medicine"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60012718",
                                "@dptid": "113122172"
                            },
                            "@affiliation-instance-id": "2015851048-7d8a2a32112872db60e101e7db04e567",
                            "ce:source-text": "Division of Endocrinology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "113122172"
                        },
                        "author": [{
                            "ce:given-name": "Boonsong",
                            "preferred-name": {
                                "ce:given-name": "Boonsong",
                                "ce:initials": "B.",
                                "ce:surname": "Ongphiphadhanakul",
                                "ce:indexed-name": "Ongphiphadhanakul B."
                            },
                            "@author-instance-id": "2015851048-4e867f607c1a9cccd14ce9553e9e5c84",
                            "@seq": "3",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Ongphiphadhanakul",
                            "@auid": "7004840966",
                            "ce:indexed-name": "Ongphiphadhanakul B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60012718",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Nephrology"},
                                {"$": "Department of Medicine"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60012718",
                                "@dptid": "113122172"
                            },
                            "@affiliation-instance-id": "2015851048-14dbb97ace0f13b15bab7dd3ce1ae8a0",
                            "ce:source-text": "Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "113122172"
                        },
                        "author": [{
                            "ce:given-name": "Kriengsak",
                            "preferred-name": {
                                "ce:given-name": "Kriengsak",
                                "ce:initials": "K.",
                                "ce:surname": "Vareesangthip",
                                "ce:indexed-name": "Vareesangthip K."
                            },
                            "@author-instance-id": "2015851048-a658bf3a9f59aebd34bdd41ff6db4790",
                            "@seq": "4",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Vareesangthip",
                            "@auid": "56871049000",
                            "ce:indexed-name": "Vareesangthip K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Endocrinology"},
                                {"$": "Department of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "127338643"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2015851048-ba9459e5fd87fbcc93ed57bd9453ecbd",
                            "ce:source-text": "Division of Endocrinology, Department of Medicine. Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "127338643"
                        },
                        "author": [{
                            "ce:given-name": "Sompongse",
                            "preferred-name": {
                                "ce:given-name": "Sompongse",
                                "ce:initials": "S.",
                                "ce:surname": "Suwanwalaikorn",
                                "ce:indexed-name": "Suwanwalaikorn S."
                            },
                            "@author-instance-id": "2015851048-51014f60b5f24dbbb325b6f991828a72",
                            "@seq": "5",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Suwanwalaikorn",
                            "@auid": "6506935197",
                            "ce:indexed-name": "Suwanwalaikorn S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Cardiovascular Medicine"},
                                {"$": "Department of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "126152981"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2015851048-d82710935b1f6f2097775eeb5529f255",
                            "ce:source-text": "Division of Cardiovascular Medicine, Department of Medicine. Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "126152981"
                        },
                        "author": [{
                            "ce:given-name": "Wacin",
                            "preferred-name": {
                                "ce:given-name": "Wacin",
                                "ce:initials": "W.",
                                "ce:surname": "Buddhari",
                                "ce:indexed-name": "Buddhari W."
                            },
                            "@author-instance-id": "2015851048-42c469fbda82b0014adaa17973b2e241",
                            "@seq": "6",
                            "ce:initials": "W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Buddhari",
                            "@auid": "57192991797",
                            "ce:indexed-name": "Buddhari W."
                        }]
                    }
                ],
                "citation-title": "The Use of SGLT2i and GLP-1 RA in patients with type 2 diabetes in thailand: Evidence review and recommendations",
                "abstracts": "© 2021 Medical Association of Thailand. All rights reserved.Background: Cardiovascular (CV) and renal comorbidities are common among type 2 diabetes (T2D) patients, and significantly increase the cost and burden of care. Both sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) improve key outcomes including major CV events, hospitalization for heart failure, and renal outcomes, albeit to varying degrees in different T2D populations. Materials and Methods: The authors reviewed evidence from GLP-1 RA and SGLT2i CV outcomes trials and real-world studies in Thailand and elsewhere. Results: The authors formulated recommendations to guide selection of anti-diabetes medication based on patients clinical characteristics and CV or renal risk profile. Conclusion: These recommendations could help guide management of CV/renal comorbidities and risk alongside glucose-lowering therapy for individual patients.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "address-part": "2 Wanglang Road",
                        "postal-code": "10700",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Cardiology"},
                            {"$": "Department of Medicine"},
                            {"$": "Mahidol University"}
                        ],
                        "ce:source-text": "Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok 10700, Thailand."
                    },
                    "person": {
                        "ce:given-name": "Rungroj",
                        "ce:initials": "R.",
                        "ce:degrees": "MD",
                        "ce:surname": "Krittayaphong",
                        "ce:indexed-name": "Krittayaphong R."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Cardiovascular diseases",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Chronic kidney disease",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Clinical outcomes",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "GLP-1 RA",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "SGLT2i",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Type 2 diabetes mellitus",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "re"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://www.jmatonline.com/index.php/jmat/article/viewfile/13163/10157",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of the Medical Association of Thailand",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "104",
                            "@issue": "11"
                        },
                        "pagerange": {
                            "@first": "1850",
                            "@last": "1865"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of the Medical Association of Thailand",
                    "publicationdate": {
                        "month": "11",
                        "year": "2021",
                        "date-text": "November 2021",
                        "day": "01"
                    },
                    "codencode": "JMTHB",
                    "sourcetitle-abbrev": "J. Med. Assoc. Thailand",
                    "@country": "tha",
                    "issn": {
                        "$": "01252208",
                        "@type": "print"
                    },
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "Medical Association of Thailand"},
                    "@srcid": "17780"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "18",
                                    "classification-description": "Cardiovascular Diseases and Cardiovascular Surgery"
                                },
                                {
                                    "classification-code": "3",
                                    "classification-description": "Endocrinology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2700"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": [
                            {
                                "cas-registry-number": [
                                    {"$": "842133-18-0"},
                                    {"$": "928672-86-0"}
                                ],
                                "chemical-name": "canagliflozin"
                            },
                            {
                                "cas-registry-number": "461432-26-8",
                                "chemical-name": "dapagliflozin"
                            },
                            {
                                "cas-registry-number": "864070-44-0",
                                "chemical-name": "empagliflozin"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "1210344-57-2"},
                                    {"$": "1210344-83-4"}
                                ],
                                "chemical-name": "ertugliflozin"
                            },
                            {
                                "cas-registry-number": "62572-11-6",
                                "chemical-name": "hemoglobin A1c"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "1115-70-4"},
                                    {"$": "657-24-9"}
                                ],
                                "chemical-name": "metformin"
                            },
                            {
                                "cas-registry-number": "1018899-04-1",
                                "chemical-name": "sotagliflozin"
                            }
                        ]
                    }}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "16",
                    "@timestamp": "BST 03:08:53",
                    "@year": "2021",
                    "@month": "12"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2015851048",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "937134360",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20211121954",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "20214852097",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20214096648",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20219021543588",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85120625176",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85120625176",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.35755/jmedassocthai.2021.11.13163"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "90",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, Bärnighausen T, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care 2018;41:963-70.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Global economic burden of diabetes in adults: projections from 2015 to 2030"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85045767187",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "963",
                                    "@last": "970"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Bommer",
                                        "ce:indexed-name": "Bommer C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Sagalova",
                                        "ce:indexed-name": "Sagalova V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Heesemann",
                                        "ce:indexed-name": "Heesemann E"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Manne-Goehler",
                                        "ce:indexed-name": "Manne-Goehler J"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Atun",
                                        "ce:indexed-name": "Atun R"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Bärnighausen",
                                        "ce:indexed-name": "Barnighausen T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, Bärnighausen T, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care 2018;41:963-70."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Reutrakul S, Deerochanawong C. Diabetes in Thailand: status and policy. Curr Diab Rep 2016;16:28.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Diabetes in Thailand: status and policy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84958778737",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {"@first": "28"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Reutrakul",
                                    "ce:indexed-name": "Reutrakul S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Deerochanawong",
                                    "ce:indexed-name": "Deerochanawong C."
                                }
                            ]},
                            "ref-sourcetitle": "Curr Diab Rep"
                        },
                        "ce:source-text": "Reutrakul S, Deerochanawong C. Diabetes in Thailand: status and policy. Curr Diab Rep 2016;16:28."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Aekplakorn W, Stolk RP, Neal B, Suriyawongpaisal P, Chongsuvivatwong V, Cheepudomwit S, et al. The prevalence and management of diabetes in Thai adults: The international collaborative study of cardiovascular disease in Asia. Diabetes Care 2003;26:2758-63.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "The prevalence and management of diabetes in Thai adults: The international collaborative study of cardiovascular disease in Asia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0141781137",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "2758",
                                    "@last": "2763"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Aekplakorn",
                                        "ce:indexed-name": "Aekplakorn W"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RP",
                                        "@_fa": "true",
                                        "ce:surname": "Stolk",
                                        "ce:indexed-name": "Stolk RP"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Neal",
                                        "ce:indexed-name": "Neal B"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Suriyawongpaisal",
                                        "ce:indexed-name": "Suriyawongpaisal P"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Chongsuvivatwong",
                                        "ce:indexed-name": "Chongsuvivatwong V"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Cheepudomwit",
                                        "ce:indexed-name": "Cheepudomwit S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "Aekplakorn W, Stolk RP, Neal B, Suriyawongpaisal P, Chongsuvivatwong V, Cheepudomwit S, et al. The prevalence and management of diabetes in Thai adults: The international collaborative study of cardiovascular disease in Asia. Diabetes Care 2003;26:2758-63."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Narindrarangkura P, Bosl W, Rangsin R, Hatthachote P. Prevalence of dyslipidemia associated with complications in diabetic patients: A nationwide study in Thailand. Lipids Health Dis 2019;18:90.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Prevalence of dyslipidemia associated with complications in diabetic patients: A nationwide study in Thailand"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85063986823",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {"@first": "90"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Narindrarangkura",
                                    "ce:indexed-name": "Narindrarangkura P"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "W",
                                    "@_fa": "true",
                                    "ce:surname": "Bosl",
                                    "ce:indexed-name": "Bosl W"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Rangsin",
                                    "ce:indexed-name": "Rangsin R"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Hatthachote",
                                    "ce:indexed-name": "Hatthachote P."
                                }
                            ]},
                            "ref-sourcetitle": "Lipids Health Dis"
                        },
                        "ce:source-text": "Narindrarangkura P, Bosl W, Rangsin R, Hatthachote P. Prevalence of dyslipidemia associated with complications in diabetic patients: A nationwide study in Thailand. Lipids Health Dis 2019;18:90."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Aekplakorn W, Chariyalertsak S, Kessomboon P, Assanangkornchai S, Taneepanichskul S, Putwatana P. Prevalence of diabetes and relationship with socioeconomic status in the thai population: National Health Examination Survey, 2004-2014. J Diabetes Res 2018;2018:1654530.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Prevalence of diabetes and relationship with socioeconomic status in the thai population: National Health Examination Survey, 2004-2014"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85048698823",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2018"},
                                "pagerange": {"@first": "1654530"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "W",
                                    "@_fa": "true",
                                    "ce:surname": "Aekplakorn",
                                    "ce:indexed-name": "Aekplakorn W"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Chariyalertsak",
                                    "ce:indexed-name": "Chariyalertsak S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Kessomboon",
                                    "ce:indexed-name": "Kessomboon P"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Assanangkornchai",
                                    "ce:indexed-name": "Assanangkornchai S"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Taneepanichskul",
                                    "ce:indexed-name": "Taneepanichskul S"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Putwatana",
                                    "ce:indexed-name": "Putwatana P."
                                }
                            ]},
                            "ref-sourcetitle": "J Diabetes Res"
                        },
                        "ce:source-text": "Aekplakorn W, Chariyalertsak S, Kessomboon P, Assanangkornchai S, Taneepanichskul S, Putwatana P. Prevalence of diabetes and relationship with socioeconomic status in the thai population: National Health Examination Survey, 2004-2014. J Diabetes Res 2018;2018:1654530."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Rawdaree P, Ngarmukos C, Deerochanawong C, Suwanwalaikorn S, Chetthakul T, Krittiyawong S, et al. Thailand diabetes registry (TDR) project: clinical status and long term vascular complications in diabetic patients. J Med Assoc Thai 2006;89 Suppl 1:S1-9.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Thailand diabetes registry (TDR) project: clinical status and long term vascular complications in diabetic patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33845411565",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "89"},
                                "pagerange": {
                                    "@first": "S1",
                                    "@last": "S9"
                                }
                            },
                            "ref-text": "Suppl 1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rawdaree",
                                        "ce:indexed-name": "Rawdaree P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Ngarmukos",
                                        "ce:indexed-name": "Ngarmukos C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Deerochanawong",
                                        "ce:indexed-name": "Deerochanawong C"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Suwanwalaikorn",
                                        "ce:indexed-name": "Suwanwalaikorn S"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Chetthakul",
                                        "ce:indexed-name": "Chetthakul T"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Krittiyawong",
                                        "ce:indexed-name": "Krittiyawong S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Med Assoc Thai"
                        },
                        "ce:source-text": "Rawdaree P, Ngarmukos C, Deerochanawong C, Suwanwalaikorn S, Chetthakul T, Krittiyawong S, et al. Thailand diabetes registry (TDR) project: clinical status and long term vascular complications in diabetic patients. J Med Assoc Thai 2006;89 Suppl 1:S1-9."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sakboonyarat B, Rangsin R. Prevalence and associated factors of ischemic heart disease (IHD) among patients with diabetes mellitus: A nation-wide, cross-sectional survey. BMC Cardiovasc Disord 2018;18:151.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Prevalence and associated factors of ischemic heart disease (IHD) among patients with diabetes mellitus: A nation-wide, cross-sectional survey"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85050644390",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {"@first": "151"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B",
                                    "@_fa": "true",
                                    "ce:surname": "Sakboonyarat",
                                    "ce:indexed-name": "Sakboonyarat B"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Rangsin",
                                    "ce:indexed-name": "Rangsin R."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Cardiovasc Disord"
                        },
                        "ce:source-text": "Sakboonyarat B, Rangsin R. Prevalence and associated factors of ischemic heart disease (IHD) among patients with diabetes mellitus: A nation-wide, cross-sectional survey. BMC Cardiovasc Disord 2018;18:151."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sriwijitkamol A, Moungngern Y, Vannaseang S. Assessment and prevalences of diabetic complications in 722 Thai type 2 diabetes patients. J Med Assoc Thai 2011;94 Suppl 1:S168-74.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Assessment and prevalences of diabetic complications in 722 Thai type 2 diabetes patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80054835457",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "94"},
                                "pagerange": {
                                    "@first": "S168",
                                    "@last": "S174"
                                }
                            },
                            "ref-text": "Suppl 1",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Sriwijitkamol",
                                    "ce:indexed-name": "Sriwijitkamol A"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Moungngern",
                                    "ce:indexed-name": "Moungngern Y"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Vannaseang",
                                    "ce:indexed-name": "Vannaseang S."
                                }
                            ]},
                            "ref-sourcetitle": "J Med Assoc Thai"
                        },
                        "ce:source-text": "Sriwijitkamol A, Moungngern Y, Vannaseang S. Assessment and prevalences of diabetic complications in 722 Thai type 2 diabetes patients. J Med Assoc Thai 2011;94 Suppl 1:S168-74."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Zhao J, Kelly M, Bain C, Seubsman SA, Sleigh A. Risk factors for cardiovascular disease mortality among 86866 members of the Thai Cohort Study, 2005-2010. Glob J Health Sci 2015;7:107-14.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Risk factors for cardiovascular disease mortality among 86866 members of the Thai Cohort Study, 2005-2010"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84925287333",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "107",
                                    "@last": "114"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Zhao",
                                    "ce:indexed-name": "Zhao J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Kelly",
                                    "ce:indexed-name": "Kelly M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Bain",
                                    "ce:indexed-name": "Bain C"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "SA",
                                    "@_fa": "true",
                                    "ce:surname": "Seubsman",
                                    "ce:indexed-name": "Seubsman SA"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Sleigh",
                                    "ce:indexed-name": "Sleigh A."
                                }
                            ]},
                            "ref-sourcetitle": "Glob J Health Sci"
                        },
                        "ce:source-text": "Zhao J, Kelly M, Bain C, Seubsman SA, Sleigh A. Risk factors for cardiovascular disease mortality among 86866 members of the Thai Cohort Study, 2005-2010. Glob J Health Sci 2015;7:107-14."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bank IEM, Gijsberts CM, Teng TK, Benson L, Sim D, Yeo PSD, et al. Prevalence and clinical significance of diabetes in Asian versus white patients with heart failure. JACC Heart Fail 2017;5:14-24.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Prevalence and clinical significance of diabetes in Asian versus white patients with heart failure"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85007613441",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "14",
                                    "@last": "24"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "IEM",
                                        "@_fa": "true",
                                        "ce:surname": "Bank",
                                        "ce:indexed-name": "Bank IEM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CM",
                                        "@_fa": "true",
                                        "ce:surname": "Gijsberts",
                                        "ce:indexed-name": "Gijsberts CM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "TK",
                                        "@_fa": "true",
                                        "ce:surname": "Teng",
                                        "ce:indexed-name": "Teng TK"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Benson",
                                        "ce:indexed-name": "Benson L"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Sim",
                                        "ce:indexed-name": "Sim D"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "PSD",
                                        "@_fa": "true",
                                        "ce:surname": "Yeo",
                                        "ce:indexed-name": "Yeo PSD"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JACC Heart Fail"
                        },
                        "ce:source-text": "Bank IEM, Gijsberts CM, Teng TK, Benson L, Sim D, Yeo PSD, et al. Prevalence and clinical significance of diabetes in Asian versus white patients with heart failure. JACC Heart Fail 2017;5:14-24."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Mentz RJ, Roessig L, Greenberg BH, Sato N, Shinagawa K, Yeo D, et al. Heart failure clinical trials in east and Southeast Asia: Understanding the importance and defining the next steps. JACC Heart Fail 2016;4:419-27.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Heart failure clinical trials in east and Southeast Asia: Understanding the importance and defining the next steps"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84977142788",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "419",
                                    "@last": "427"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RJ",
                                        "@_fa": "true",
                                        "ce:surname": "Mentz",
                                        "ce:indexed-name": "Mentz RJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Roessig",
                                        "ce:indexed-name": "Roessig L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "BH",
                                        "@_fa": "true",
                                        "ce:surname": "Greenberg",
                                        "ce:indexed-name": "Greenberg BH"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Sato",
                                        "ce:indexed-name": "Sato N"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Shinagawa",
                                        "ce:indexed-name": "Shinagawa K"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Yeo",
                                        "ce:indexed-name": "Yeo D"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JACC Heart Fail"
                        },
                        "ce:source-text": "Mentz RJ, Roessig L, Greenberg BH, Sato N, Shinagawa K, Yeo D, et al. Heart failure clinical trials in east and Southeast Asia: Understanding the importance and defining the next steps. JACC Heart Fail 2016;4:419-27."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Tromp J, Tay WT, Ouwerkerk W, Teng TK, Yap J, MacDonald MR, et al. Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry. PLoS Med 2018;15:e1002541.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85045682649",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {"@first": "e1002541"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Tromp",
                                        "ce:indexed-name": "Tromp J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WT",
                                        "@_fa": "true",
                                        "ce:surname": "Tay",
                                        "ce:indexed-name": "Tay WT"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Ouwerkerk",
                                        "ce:indexed-name": "Ouwerkerk W"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "TK",
                                        "@_fa": "true",
                                        "ce:surname": "Teng",
                                        "ce:indexed-name": "Teng TK"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Yap",
                                        "ce:indexed-name": "Yap J"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "MR",
                                        "@_fa": "true",
                                        "ce:surname": "MacDonald",
                                        "ce:indexed-name": "MacDonald MR"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS Med"
                        },
                        "ce:source-text": "Tromp J, Tay WT, Ouwerkerk W, Teng TK, Yap J, MacDonald MR, et al. Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry. PLoS Med 2018;15:e1002541."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Krittayaphong R, Karaketklang K, Yindeengam A, Janwanishstaporn S. Heart failure mortality compared between elderly and non-elderly Thai patients. J Geriatr Cardiol 2018;15:718-24.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Heart failure mortality compared between elderly and non-elderly Thai patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85060084835",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "718",
                                    "@last": "724"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Krittayaphong",
                                    "ce:indexed-name": "Krittayaphong R"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Karaketklang",
                                    "ce:indexed-name": "Karaketklang K"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Yindeengam",
                                    "ce:indexed-name": "Yindeengam A"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Janwanishstaporn",
                                    "ce:indexed-name": "Janwanishstaporn S."
                                }
                            ]},
                            "ref-sourcetitle": "J Geriatr Cardiol"
                        },
                        "ce:source-text": "Krittayaphong R, Karaketklang K, Yindeengam A, Janwanishstaporn S. Heart failure mortality compared between elderly and non-elderly Thai patients. J Geriatr Cardiol 2018;15:718-24."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Doshi SM, Friedman AN. Diagnosis and management of type 2 diabetic kidney disease. Clin J Am Soc Nephrol 2017;12:1366-73.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Diagnosis and management of type 2 diabetic kidney disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85025468669",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "1366",
                                    "@last": "1373"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "SM",
                                    "@_fa": "true",
                                    "ce:surname": "Doshi",
                                    "ce:indexed-name": "Doshi SM"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "AN.",
                                    "@_fa": "true",
                                    "ce:surname": "Friedman",
                                    "ce:indexed-name": "Friedman AN."
                                }
                            ]},
                            "ref-sourcetitle": "Clin J Am Soc Nephrol"
                        },
                        "ce:source-text": "Doshi SM, Friedman AN. Diagnosis and management of type 2 diabetic kidney disease. Clin J Am Soc Nephrol 2017;12:1366-73."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA 2016;316:602-10.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84981201088",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "316"},
                                "pagerange": {
                                    "@first": "602",
                                    "@last": "610"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Afkarian",
                                        "ce:indexed-name": "Afkarian M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "LR",
                                        "@_fa": "true",
                                        "ce:surname": "Zelnick",
                                        "ce:indexed-name": "Zelnick LR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "YN",
                                        "@_fa": "true",
                                        "ce:surname": "Hall",
                                        "ce:indexed-name": "Hall YN"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "PJ",
                                        "@_fa": "true",
                                        "ce:surname": "Heagerty",
                                        "ce:indexed-name": "Heagerty PJ"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Tuttle",
                                        "ce:indexed-name": "Tuttle K"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "NS",
                                        "@_fa": "true",
                                        "ce:surname": "Weiss",
                                        "ce:indexed-name": "Weiss NS"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA"
                        },
                        "ce:source-text": "Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA 2016;316:602-10."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011;305:2532-9.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Temporal trends in the prevalence of diabetic kidney disease in the United States"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79959487586",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "305"},
                                "pagerange": {
                                    "@first": "2532",
                                    "@last": "2539"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "IH",
                                    "@_fa": "true",
                                    "ce:surname": "de Boer",
                                    "ce:indexed-name": "de Boer IH"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "TC",
                                    "@_fa": "true",
                                    "ce:surname": "Rue",
                                    "ce:indexed-name": "Rue TC"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "YN",
                                    "@_fa": "true",
                                    "ce:surname": "Hall",
                                    "ce:indexed-name": "Hall YN"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "PJ",
                                    "@_fa": "true",
                                    "ce:surname": "Heagerty",
                                    "ce:indexed-name": "Heagerty PJ"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "NS",
                                    "@_fa": "true",
                                    "ce:surname": "Weiss",
                                    "ce:indexed-name": "Weiss NS"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Himmelfarb",
                                    "ce:indexed-name": "Himmelfarb J."
                                }
                            ]},
                            "ref-sourcetitle": "JAMA"
                        },
                        "ce:source-text": "de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011;305:2532-9."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Chuasuwan A, Lumpaopong A. Thailand Renal Replacement Therapy. Bangkok: The Nephrology Society of Thailand; 2015.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85041068873",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Bangkok: The Nephrology Society of Thailand",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Chuasuwan",
                                    "ce:indexed-name": "Chuasuwan A"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Lumpaopong",
                                    "ce:indexed-name": "Lumpaopong A."
                                }
                            ]},
                            "ref-sourcetitle": "Thailand Renal Replacement Therapy"
                        },
                        "ce:source-text": "Chuasuwan A, Lumpaopong A. Thailand Renal Replacement Therapy. Bangkok: The Nephrology Society of Thailand; 2015."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Nata N, Rangsin R, Supasyndh O, Satirapoj B. Impaired glomerular filtration rate in type 2 diabetes mellitus subjects: A nationwide cross-sectional study in Thailand. J Diabetes Res 2020;2020:6353949.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Impaired glomerular filtration rate in type 2 diabetes mellitus subjects: A nationwide cross-sectional study in Thailand"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85089996870",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2020"},
                                "pagerange": {"@first": "6353949"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Nata",
                                    "ce:indexed-name": "Nata N"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Rangsin",
                                    "ce:indexed-name": "Rangsin R"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "O",
                                    "@_fa": "true",
                                    "ce:surname": "Supasyndh",
                                    "ce:indexed-name": "Supasyndh O"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Satirapoj",
                                    "ce:indexed-name": "Satirapoj B."
                                }
                            ]},
                            "ref-sourcetitle": "J Diabetes Res"
                        },
                        "ce:source-text": "Nata N, Rangsin R, Supasyndh O, Satirapoj B. Impaired glomerular filtration rate in type 2 diabetes mellitus subjects: A nationwide cross-sectional study in Thailand. J Diabetes Res 2020;2020:6353949."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kaewput W, Thongprayoon C, Rangsin R, Mao MA, Satirapoj B, Cheungpasitporn W. The association between renal function and neurological diseases in type 2 diabetes: A multicenter nationwide crosssectional study. Hosp Pract (1995) 2019;47:46-52.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "The association between renal function and neurological diseases in type 2 diabetes: A multicenter nationwide crosssectional study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85060517865",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "47"},
                                "pagerange": {
                                    "@first": "46",
                                    "@last": "52"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "W",
                                    "@_fa": "true",
                                    "ce:surname": "Kaewput",
                                    "ce:indexed-name": "Kaewput W"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Thongprayoon",
                                    "ce:indexed-name": "Thongprayoon C"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Rangsin",
                                    "ce:indexed-name": "Rangsin R"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "MA",
                                    "@_fa": "true",
                                    "ce:surname": "Mao",
                                    "ce:indexed-name": "Mao MA"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "B",
                                    "@_fa": "true",
                                    "ce:surname": "Satirapoj",
                                    "ce:indexed-name": "Satirapoj B"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheungpasitporn",
                                    "ce:indexed-name": "Cheungpasitporn W."
                                }
                            ]},
                            "ref-sourcetitle": "Hosp Pract (1995)"
                        },
                        "ce:source-text": "Kaewput W, Thongprayoon C, Rangsin R, Mao MA, Satirapoj B, Cheungpasitporn W. The association between renal function and neurological diseases in type 2 diabetes: A multicenter nationwide crosssectional study. Hosp Pract (1995) 2019;47:46-52."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kaewput W, Thongprayoon C, Rangsin R, Ruangkanchanasetr P, Mao MA, Cheungpasitporn W. Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: A multicenter nationwide cross-sectional study. World J Nephrol 2019;8:33-43.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: A multicenter nationwide cross-sectional study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85071279322",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "33",
                                    "@last": "43"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "W",
                                    "@_fa": "true",
                                    "ce:surname": "Kaewput",
                                    "ce:indexed-name": "Kaewput W"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Thongprayoon",
                                    "ce:indexed-name": "Thongprayoon C"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Rangsin",
                                    "ce:indexed-name": "Rangsin R"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Ruangkanchanasetr",
                                    "ce:indexed-name": "Ruangkanchanasetr P"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "MA",
                                    "@_fa": "true",
                                    "ce:surname": "Mao",
                                    "ce:indexed-name": "Mao MA"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheungpasitporn",
                                    "ce:indexed-name": "Cheungpasitporn W."
                                }
                            ]},
                            "ref-sourcetitle": "World J Nephrol"
                        },
                        "ce:source-text": "Kaewput W, Thongprayoon C, Rangsin R, Ruangkanchanasetr P, Mao MA, Cheungpasitporn W. Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: A multicenter nationwide cross-sectional study. World J Nephrol 2019;8:33-43."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Krairittichai U, Potisat S. Survival rates and mortality risk factors of Thai patients with type 2 diabetes mellitus. J Med Assoc Thai 2017;100 Suppl 1:S8-15.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Survival rates and mortality risk factors of Thai patients with type 2 diabetes mellitus"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85120623762",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "100"},
                                "pagerange": {
                                    "@first": "S8",
                                    "@last": "15"
                                }
                            },
                            "ref-text": "Suppl 1",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "U",
                                    "@_fa": "true",
                                    "ce:surname": "Krairittichai",
                                    "ce:indexed-name": "Krairittichai U"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Potisat",
                                    "ce:indexed-name": "Potisat S."
                                }
                            ]},
                            "ref-sourcetitle": "J Med Assoc Thai"
                        },
                        "ce:source-text": "Krairittichai U, Potisat S. Survival rates and mortality risk factors of Thai patients with type 2 diabetes mellitus. J Med Assoc Thai 2017;100 Suppl 1:S8-15."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "American Diabetes Association. 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2019. Diabetes Care 2019;42(Suppl 1):S103-23.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Cardiovascular disease and risk management: standards of medical care in diabetes-2019"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85058765752",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "42"},
                                "pagerange": {
                                    "@first": "S103",
                                    "@last": "S123"
                                }
                            },
                            "ref-text": "American Diabetes Association. 10. ;(Suppl 1)",
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "American Diabetes Association. 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2019. Diabetes Care 2019;42(Suppl 1):S103-23."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cefalu WT, Kaul S, Gerstein HC, Holman RR, Zinman B, Skyler JS, et al. Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a Diabetes Care Editors Expert Forum. Diabetes Care 2018;41:14-31.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a Diabetes Care Editors Expert Forum"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85038951494",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "14",
                                    "@last": "31"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "WT",
                                        "@_fa": "true",
                                        "ce:surname": "Cefalu",
                                        "ce:indexed-name": "Cefalu WT"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Kaul",
                                        "ce:indexed-name": "Kaul S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "HC",
                                        "@_fa": "true",
                                        "ce:surname": "Gerstein",
                                        "ce:indexed-name": "Gerstein HC"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "RR",
                                        "@_fa": "true",
                                        "ce:surname": "Holman",
                                        "ce:indexed-name": "Holman RR"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Zinman",
                                        "ce:indexed-name": "Zinman B"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "JS",
                                        "@_fa": "true",
                                        "ce:surname": "Skyler",
                                        "ce:indexed-name": "Skyler JS"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "Cefalu WT, Kaul S, Gerstein HC, Holman RR, Zinman B, Skyler JS, et al. Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a Diabetes Care Editors Expert Forum. Diabetes Care 2018;41:14-31."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "US Food and Drug Administration. Guidance for industry diabetes mellitus-evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. Washington, D.C.: The United States Department of Health and Human Services; 2008.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "refd-itemidlist": {"itemid": {
                                "$": "72249116214",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "US Food and Drug Administration. Washington, D.C.: The United States Department of Health and Human Services",
                            "ref-sourcetitle": "Guidance for industry diabetes mellitus-evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes"
                        },
                        "ce:source-text": "US Food and Drug Administration. Guidance for industry diabetes mellitus-evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. Washington, D.C.: The United States Department of Health and Human Services; 2008."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Fioretto P, Zambon A, Rossato M, Busetto L, Vettor R. SGLT2 inhibitors and the diabetic kidney. Diabetes Care 2016;39 Suppl 2:S165-71.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "SGLT2 inhibitors and the diabetic kidney"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84979582003",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "39"},
                                "pagerange": {
                                    "@first": "S165",
                                    "@last": "S171"
                                }
                            },
                            "ref-text": "Suppl 2",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Fioretto",
                                    "ce:indexed-name": "Fioretto P"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Zambon",
                                    "ce:indexed-name": "Zambon A"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Rossato",
                                    "ce:indexed-name": "Rossato M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Busetto",
                                    "ce:indexed-name": "Busetto L"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Vettor",
                                    "ce:indexed-name": "Vettor R."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "Fioretto P, Zambon A, Rossato M, Busetto L, Vettor R. SGLT2 inhibitors and the diabetic kidney. Diabetes Care 2016;39 Suppl 2:S165-71."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med 2020;383:1436-46.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Dapagliflozin in patients with chronic kidney disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85092598310",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "383"},
                                "pagerange": {
                                    "@first": "1436",
                                    "@last": "1446"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HJL",
                                        "@_fa": "true",
                                        "ce:surname": "Heerspink",
                                        "ce:indexed-name": "Heerspink HJL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BV",
                                        "@_fa": "true",
                                        "ce:surname": "Stefánsson",
                                        "ce:indexed-name": "Stefansson BV"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Correa-Rotter",
                                        "ce:indexed-name": "Correa-Rotter R"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "GM",
                                        "@_fa": "true",
                                        "ce:surname": "Chertow",
                                        "ce:indexed-name": "Chertow GM"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Greene",
                                        "ce:indexed-name": "Greene T"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "FF",
                                        "@_fa": "true",
                                        "ce:surname": "Hou",
                                        "ce:indexed-name": "Hou FF"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med 2020;383:1436-46."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 2019;380:2295-306.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Canagliflozin and renal outcomes in type 2 diabetes and nephropathy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85066483412",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "380"},
                                "pagerange": {
                                    "@first": "2295",
                                    "@last": "2306"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Perkovic",
                                        "ce:indexed-name": "Perkovic V"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MJ",
                                        "@_fa": "true",
                                        "ce:surname": "Jardine",
                                        "ce:indexed-name": "Jardine MJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Neal",
                                        "ce:indexed-name": "Neal B"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Bompoint",
                                        "ce:indexed-name": "Bompoint S"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "HJL",
                                        "@_fa": "true",
                                        "ce:surname": "Heerspink",
                                        "ce:indexed-name": "Heerspink HJL"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "DM",
                                        "@_fa": "true",
                                        "ce:surname": "Charytan",
                                        "ce:indexed-name": "Charytan DM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 2019;380:2295-306."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Zurek AM, Yendapally R, Urteaga EM. A review of the efficacy and safety of sodium-glucose cotransporter 2 inhibitors: A focus on diabetic ketoacidosis. Diabetes Spectr 2017;30:137-42.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "A review of the efficacy and safety of sodium-glucose cotransporter 2 inhibitors: A focus on diabetic ketoacidosis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85019645232",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "137",
                                    "@last": "142"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AM",
                                    "@_fa": "true",
                                    "ce:surname": "Zurek",
                                    "ce:indexed-name": "Zurek AM"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Yendapally",
                                    "ce:indexed-name": "Yendapally R"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "EM.",
                                    "@_fa": "true",
                                    "ce:surname": "Urteaga",
                                    "ce:indexed-name": "Urteaga EM."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Spectr"
                        },
                        "ce:source-text": "Zurek AM, Yendapally R, Urteaga EM. A review of the efficacy and safety of sodium-glucose cotransporter 2 inhibitors: A focus on diabetic ketoacidosis. Diabetes Spectr 2017;30:137-42."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Zaccardi F, Webb DR, Htike ZZ, Youssef D, Khunti K, Davies MJ. Efficacy and safety of sodium-glucose co-Transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-Analysis. Diabetes Obes Metab 2016;18:783-94.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of sodium-glucose co-Transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-Analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84969915634",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "783",
                                    "@last": "794"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Zaccardi",
                                    "ce:indexed-name": "Zaccardi F"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "DR",
                                    "@_fa": "true",
                                    "ce:surname": "Webb",
                                    "ce:indexed-name": "Webb DR"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "ZZ",
                                    "@_fa": "true",
                                    "ce:surname": "Htike",
                                    "ce:indexed-name": "Htike ZZ"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Youssef",
                                    "ce:indexed-name": "Youssef D"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Khunti",
                                    "ce:indexed-name": "Khunti K"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "MJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Davies",
                                    "ce:indexed-name": "Davies MJ."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Obes Metab"
                        },
                        "ce:source-text": "Zaccardi F, Webb DR, Htike ZZ, Youssef D, Khunti K, Davies MJ. Efficacy and safety of sodium-glucose co-Transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-Analysis. Diabetes Obes Metab 2016;18:783-94."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cai X, Gao X, Yang W, Chen Y, Zhang S, Zhou L, et al. No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: A meta-Analysis. J Diabetes Investig 2018;9:850-61.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: A meta-Analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85047965804",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "850",
                                    "@last": "861"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X",
                                        "@_fa": "true",
                                        "ce:surname": "Cai",
                                        "ce:indexed-name": "Cai X"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "X",
                                        "@_fa": "true",
                                        "ce:surname": "Gao",
                                        "ce:indexed-name": "Gao X"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang W"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen Y"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang S"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Diabetes Investig"
                        },
                        "ce:source-text": "Cai X, Gao X, Yang W, Chen Y, Zhang S, Zhou L, et al. No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: A meta-Analysis. J Diabetes Investig 2018;9:850-61."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "van Baar MJB, van Ruiten CC, Muskiet MHA, van Bloemendaal L, RG IJ, van Raalte DH. SGLT2 inhibitors in combination therapy: From mechanisms to clinical considerations in type 2 diabetes management. Diabetes Care 2018;41:1543-56.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "SGLT2 inhibitors in combination therapy: From mechanisms to clinical considerations in type 2 diabetes management"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85053563266",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "1543",
                                    "@last": "1556"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "MJB",
                                    "@_fa": "true",
                                    "ce:surname": "van Baar",
                                    "ce:indexed-name": "van Baar MJB"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "CC",
                                    "@_fa": "true",
                                    "ce:surname": "van Ruiten",
                                    "ce:indexed-name": "van Ruiten CC"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "MHA",
                                    "@_fa": "true",
                                    "ce:surname": "Muskiet",
                                    "ce:indexed-name": "Muskiet MHA"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "van Bloemendaal",
                                    "ce:indexed-name": "van Bloemendaal L"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "IJ",
                                    "@_fa": "true",
                                    "ce:surname": "RG",
                                    "ce:indexed-name": "RG IJ"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "DH.",
                                    "@_fa": "true",
                                    "ce:surname": "van Raalte",
                                    "ce:indexed-name": "van Raalte DH."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "van Baar MJB, van Ruiten CC, Muskiet MHA, van Bloemendaal L, RG IJ, van Raalte DH. SGLT2 inhibitors in combination therapy: From mechanisms to clinical considerations in type 2 diabetes management. Diabetes Care 2018;41:1543-56."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2019;380:347-57.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Dapagliflozin and cardiovascular outcomes in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85060042753",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "380"},
                                "pagerange": {
                                    "@first": "347",
                                    "@last": "357"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SD",
                                        "@_fa": "true",
                                        "ce:surname": "Wiviott",
                                        "ce:indexed-name": "Wiviott SD"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Raz",
                                        "ce:indexed-name": "Raz I"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MP",
                                        "@_fa": "true",
                                        "ce:surname": "Bonaca",
                                        "ce:indexed-name": "Bonaca MP"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "O",
                                        "@_fa": "true",
                                        "ce:surname": "Mosenzon",
                                        "ce:indexed-name": "Mosenzon O"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "ET",
                                        "@_fa": "true",
                                        "ce:surname": "Kato",
                                        "ce:indexed-name": "Kato ET"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Cahn",
                                        "ce:indexed-name": "Cahn A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2019;380:347-57."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Davies MJ, D Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018;41:2669-701.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85056802117",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "2669",
                                    "@last": "2701"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MJ",
                                        "@_fa": "true",
                                        "ce:surname": "Davies",
                                        "ce:indexed-name": "Davies MJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DA",
                                        "@_fa": "true",
                                        "ce:surname": "D Alessio",
                                        "ce:indexed-name": "D Alessio DA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Fradkin",
                                        "ce:indexed-name": "Fradkin J"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "WN",
                                        "@_fa": "true",
                                        "ce:surname": "Kernan",
                                        "ce:indexed-name": "Kernan WN"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Mathieu",
                                        "ce:indexed-name": "Mathieu C"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Mingrone",
                                        "ce:indexed-name": "Mingrone G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "Davies MJ, D Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018;41:2669-701."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: A systematic review and meta-Analysis of cardiovascular outcome trials. Lancet 2019;393:31-9.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: A systematic review and meta-Analysis of cardiovascular outcome trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85059501499",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "393"},
                                "pagerange": {
                                    "@first": "31",
                                    "@last": "39"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "TA",
                                        "@_fa": "true",
                                        "ce:surname": "Zelniker",
                                        "ce:indexed-name": "Zelniker TA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SD",
                                        "@_fa": "true",
                                        "ce:surname": "Wiviott",
                                        "ce:indexed-name": "Wiviott SD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Raz",
                                        "ce:indexed-name": "Raz I"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im K"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "EL",
                                        "@_fa": "true",
                                        "ce:surname": "Goodrich",
                                        "ce:indexed-name": "Goodrich EL"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "MP",
                                        "@_fa": "true",
                                        "ce:surname": "Bonaca",
                                        "ce:indexed-name": "Bonaca MP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: A systematic review and meta-Analysis of cardiovascular outcome trials. Lancet 2019;393:31-9."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Thewjitcharoen Y, Yenseung N, Malidaeng A, Nakasatien S, Chotwanvirat P, Krittiyawong S, et al. Effectiveness of long-Term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center. Diabetol Metab Syndr 2017;9:96.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Effectiveness of long-Term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85037045257",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "96"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Thewjitcharoen",
                                        "ce:indexed-name": "Thewjitcharoen Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Yenseung",
                                        "ce:indexed-name": "Yenseung N"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Malidaeng",
                                        "ce:indexed-name": "Malidaeng A"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Nakasatien",
                                        "ce:indexed-name": "Nakasatien S"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Chotwanvirat",
                                        "ce:indexed-name": "Chotwanvirat P"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Krittiyawong",
                                        "ce:indexed-name": "Krittiyawong S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetol Metab Syndr"
                        },
                        "ce:source-text": "Thewjitcharoen Y, Yenseung N, Malidaeng A, Nakasatien S, Chotwanvirat P, Krittiyawong S, et al. Effectiveness of long-Term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center. Diabetol Metab Syndr 2017;9:96."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Zhang M, Zhang L, Wu B, Song H, An Z, Li S. Dapagliflozin treatment for type 2 diabetes: A systematic review and meta-Analysis of randomized controlled trials. Diabetes Metab Res Rev 2014;30:204-21.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Dapagliflozin treatment for type 2 diabetes: A systematic review and meta-Analysis of randomized controlled trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84895484977",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "204",
                                    "@last": "221"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu B"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Song",
                                    "ce:indexed-name": "Song H"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "Z",
                                    "@_fa": "true",
                                    "ce:surname": "An",
                                    "ce:indexed-name": "An Z"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li S."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Metab Res Rev"
                        },
                        "ce:source-text": "Zhang M, Zhang L, Wu B, Song H, An Z, Li S. Dapagliflozin treatment for type 2 diabetes: A systematic review and meta-Analysis of randomized controlled trials. Diabetes Metab Res Rev 2014;30:204-21."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sriphrapradang C, Thewjitcharoen Y, Buranapin S, Sawanyawisuth K, Yenseung N, Ubonchareon W, et al. Effectiveness and safety of sodium-glucose co-Transporter-2 inhibitors in Thai adults with type 2 diabetes mellitus: A real-world study. Curr Med Res Opin 2020;36:1601-10.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Effectiveness and safety of sodium-glucose co-Transporter-2 inhibitors in Thai adults with type 2 diabetes mellitus: A real-world study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85089919246",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "36"},
                                "pagerange": {
                                    "@first": "1601",
                                    "@last": "1610"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Sriphrapradang",
                                        "ce:indexed-name": "Sriphrapradang C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Thewjitcharoen",
                                        "ce:indexed-name": "Thewjitcharoen Y"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Buranapin",
                                        "ce:indexed-name": "Buranapin S"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Sawanyawisuth",
                                        "ce:indexed-name": "Sawanyawisuth K"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Yenseung",
                                        "ce:indexed-name": "Yenseung N"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Ubonchareon",
                                        "ce:indexed-name": "Ubonchareon W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Curr Med Res Opin"
                        },
                        "ce:source-text": "Sriphrapradang C, Thewjitcharoen Y, Buranapin S, Sawanyawisuth K, Yenseung N, Ubonchareon W, et al. Effectiveness and safety of sodium-glucose co-Transporter-2 inhibitors in Thai adults with type 2 diabetes mellitus: A real-world study. Curr Med Res Opin 2020;36:1601-10."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Donnan JR, Grandy CA, Chibrikov E, Marra CA, Aubrey-Bassler K, Johnston K, et al. Comparative safety of the sodium glucose co-Transporter 2 (SGLT2) inhibitors: A systematic review and meta-Analysis. BMJ Open 2019;9:e022577.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Comparative safety of the sodium glucose co-Transporter 2 (SGLT2) inhibitors: A systematic review and meta-Analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85061042887",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "e022577"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JR",
                                        "@_fa": "true",
                                        "ce:surname": "Donnan",
                                        "ce:indexed-name": "Donnan JR"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CA",
                                        "@_fa": "true",
                                        "ce:surname": "Grandy",
                                        "ce:indexed-name": "Grandy CA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Chibrikov",
                                        "ce:indexed-name": "Chibrikov E"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "CA",
                                        "@_fa": "true",
                                        "ce:surname": "Marra",
                                        "ce:indexed-name": "Marra CA"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Aubrey-Bassler",
                                        "ce:indexed-name": "Aubrey-Bassler K"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Johnston",
                                        "ce:indexed-name": "Johnston K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMJ Open"
                        },
                        "ce:source-text": "Donnan JR, Grandy CA, Chibrikov E, Marra CA, Aubrey-Bassler K, Johnston K, et al. Comparative safety of the sodium glucose co-Transporter 2 (SGLT2) inhibitors: A systematic review and meta-Analysis. BMJ Open 2019;9:e022577."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bagepally BS, Gurav YK, Anothaisintawee T, Youngkong S, Chaikledkaew U, Thakkinstian A. Cost utility of sodium-glucose cotransporter 2 inhibitors in the treatment of metformin monotherapy failed type 2 diabetes patients: A systematic review and metaanalysis. Value Health 2019;22:1458-69.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Cost utility of sodium-glucose cotransporter 2 inhibitors in the treatment of metformin monotherapy failed type 2 diabetes patients: A systematic review and metaanalysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85075456470",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "1458",
                                    "@last": "1469"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "BS",
                                    "@_fa": "true",
                                    "ce:surname": "Bagepally",
                                    "ce:indexed-name": "Bagepally BS"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "YK",
                                    "@_fa": "true",
                                    "ce:surname": "Gurav",
                                    "ce:indexed-name": "Gurav YK"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Anothaisintawee",
                                    "ce:indexed-name": "Anothaisintawee T"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Youngkong",
                                    "ce:indexed-name": "Youngkong S"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "U",
                                    "@_fa": "true",
                                    "ce:surname": "Chaikledkaew",
                                    "ce:indexed-name": "Chaikledkaew U"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Thakkinstian",
                                    "ce:indexed-name": "Thakkinstian A."
                                }
                            ]},
                            "ref-sourcetitle": "Value Health"
                        },
                        "ce:source-text": "Bagepally BS, Gurav YK, Anothaisintawee T, Youngkong S, Chaikledkaew U, Thakkinstian A. Cost utility of sodium-glucose cotransporter 2 inhibitors in the treatment of metformin monotherapy failed type 2 diabetes patients: A systematic review and metaanalysis. Value Health 2019;22:1458-69."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Krittayaphong R, Permsuwan U. Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction. Int J Cardiol 2021;322:183-90.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85089826614",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "322"},
                                "pagerange": {
                                    "@first": "183",
                                    "@last": "190"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Krittayaphong",
                                    "ce:indexed-name": "Krittayaphong R"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "U.",
                                    "@_fa": "true",
                                    "ce:surname": "Permsuwan",
                                    "ce:indexed-name": "Permsuwan U."
                                }
                            ]},
                            "ref-sourcetitle": "Int J Cardiol"
                        },
                        "ce:source-text": "Krittayaphong R, Permsuwan U. Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction. Int J Cardiol 2021;322:183-90."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kosiborod M, Berwanger O, Koch GG, Martinez F, Mukhtar O, Verma S, et al. Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study. Diabetes Obes Metab 2021;23:886-96.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85099580131",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "886",
                                    "@last": "896"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Kosiborod",
                                        "ce:indexed-name": "Kosiborod M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O",
                                        "@_fa": "true",
                                        "ce:surname": "Berwanger",
                                        "ce:indexed-name": "Berwanger O"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GG",
                                        "@_fa": "true",
                                        "ce:surname": "Koch",
                                        "ce:indexed-name": "Koch GG"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Martinez",
                                        "ce:indexed-name": "Martinez F"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "O",
                                        "@_fa": "true",
                                        "ce:surname": "Mukhtar",
                                        "ce:indexed-name": "Mukhtar O"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Verma",
                                        "ce:indexed-name": "Verma S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Obes Metab"
                        },
                        "ce:source-text": "Kosiborod M, Berwanger O, Koch GG, Martinez F, Mukhtar O, Verma S, et al. Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study. Diabetes Obes Metab 2021;23:886-96."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Chatterjee S. SGLT-2 inhibitors for COVID-19-A miracle waiting to happen or just another beat around the bush? Prim Care Diabetes 2020;14:564-5.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "SGLT-2 inhibitors for COVID-19-A miracle waiting to happen or just another beat around the bush?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85086402072",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "564",
                                    "@last": "565"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "ce:surname": "Chatterjee",
                                "ce:indexed-name": "Chatterjee S."
                            }]},
                            "ref-sourcetitle": "Prim Care Diabetes"
                        },
                        "ce:source-text": "Chatterjee S. SGLT-2 inhibitors for COVID-19-A miracle waiting to happen or just another beat around the bush? Prim Care Diabetes 2020;14:564-5."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Aroda VR. A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials. Diabetes Obes Metab 2018;20 Suppl 1:22-33.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85041084528",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "22",
                                    "@last": "33"
                                }
                            },
                            "ref-text": "Suppl 1",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "VR.",
                                "@_fa": "true",
                                "ce:surname": "Aroda",
                                "ce:indexed-name": "Aroda VR."
                            }]},
                            "ref-sourcetitle": "Diabetes Obes Metab"
                        },
                        "ce:source-text": "Aroda VR. A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials. Diabetes Obes Metab 2018;20 Suppl 1:22-33."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Zhang F, Tang L, Zhang Y, Lö Q, Tong N. Glucagonlike peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-Analysis of randomized controlled trials. Sci Rep 2017;7:15997.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Glucagonlike peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-Analysis of randomized controlled trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85034816469",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "15997"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang F"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Tang",
                                    "ce:indexed-name": "Tang L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang Y"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "Q",
                                    "@_fa": "true",
                                    "ce:surname": "Lö",
                                    "ce:indexed-name": "Lo Q"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Tong",
                                    "ce:indexed-name": "Tong N."
                                }
                            ]},
                            "ref-sourcetitle": "Sci Rep"
                        },
                        "ce:source-text": "Zhang F, Tang L, Zhang Y, Lö Q, Tong N. Glucagonlike peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-Analysis of randomized controlled trials. Sci Rep 2017;7:15997."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kim YG, Hahn S, Oh TJ, Park KS, Cho YM. Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: A systematic review and meta-Analysis. Diabetes Obes Metab 2014;16:900-9.",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: A systematic review and meta-Analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84912565672",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "900",
                                    "@last": "909"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "YG",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim YG"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Hahn",
                                    "ce:indexed-name": "Hahn S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "TJ",
                                    "@_fa": "true",
                                    "ce:surname": "Oh",
                                    "ce:indexed-name": "Oh TJ"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "KS",
                                    "@_fa": "true",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park KS"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "YM.",
                                    "@_fa": "true",
                                    "ce:surname": "Cho",
                                    "ce:indexed-name": "Cho YM."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Obes Metab"
                        },
                        "ce:source-text": "Kim YG, Hahn S, Oh TJ, Park KS, Cho YM. Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: A systematic review and meta-Analysis. Diabetes Obes Metab 2014;16:900-9."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sun F, Wu S, Wang J, Guo S, Chai S, Yang Z, et al. Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: A systematic review and network meta-Analysis. Clin Ther 2015;37:225-41.e8.",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: A systematic review and network meta-Analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84920855422",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "225",
                                    "@last": "241"
                                }
                            },
                            "ref-text": "e8",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Sun",
                                        "ce:indexed-name": "Sun F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang J"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Guo",
                                        "ce:indexed-name": "Guo S"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Chai",
                                        "ce:indexed-name": "Chai S"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang Z"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Ther"
                        },
                        "ce:source-text": "Sun F, Wu S, Wang J, Guo S, Chai S, Yang Z, et al. Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: A systematic review and network meta-Analysis. Clin Ther 2015;37:225-41.e8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Thrasher J. Pharmacologic management of type 2 diabetes mellitus: Available therapies. Am J Med 2017;130:S4-17.",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Pharmacologic management of type 2 diabetes mellitus: Available therapies"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85019983309",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "130"},
                                "pagerange": {
                                    "@first": "S4",
                                    "@last": "17"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "ce:surname": "Thrasher",
                                "ce:indexed-name": "Thrasher J."
                            }]},
                            "ref-sourcetitle": "Am J Med"
                        },
                        "ce:source-text": "Thrasher J. Pharmacologic management of type 2 diabetes mellitus: Available therapies. Am J Med 2017;130:S4-17."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bagepally BS, Chaikledkaew U, Gurav YK, Anothaisintawee T, Youngkong S, Chaiyakunapruk N, et al. Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-Analysis of economic evaluation studies. BMJ Open Diabetes Res Care 2020;8:e001020.",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-Analysis of economic evaluation studies"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85088458420",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "e001020"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BS",
                                        "@_fa": "true",
                                        "ce:surname": "Bagepally",
                                        "ce:indexed-name": "Bagepally BS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "U",
                                        "@_fa": "true",
                                        "ce:surname": "Chaikledkaew",
                                        "ce:indexed-name": "Chaikledkaew U"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "YK",
                                        "@_fa": "true",
                                        "ce:surname": "Gurav",
                                        "ce:indexed-name": "Gurav YK"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Anothaisintawee",
                                        "ce:indexed-name": "Anothaisintawee T"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Youngkong",
                                        "ce:indexed-name": "Youngkong S"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Chaiyakunapruk",
                                        "ce:indexed-name": "Chaiyakunapruk N"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMJ Open Diabetes Res Care"
                        },
                        "ce:source-text": "Bagepally BS, Chaikledkaew U, Gurav YK, Anothaisintawee T, Youngkong S, Chaiyakunapruk N, et al. Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-Analysis of economic evaluation studies. BMJ Open Diabetes Res Care 2020;8:e001020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Deerochanawong C, Kosachunhanun N, Gadekar AV, Chotikanokrat P, Permsuwan U. Cost-benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand. Clinicoecon Outcomes Res 2019;11:423-30.",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Cost-benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85071682129",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "423",
                                    "@last": "430"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Deerochanawong",
                                    "ce:indexed-name": "Deerochanawong C"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Kosachunhanun",
                                    "ce:indexed-name": "Kosachunhanun N"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "AV",
                                    "@_fa": "true",
                                    "ce:surname": "Gadekar",
                                    "ce:indexed-name": "Gadekar AV"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Chotikanokrat",
                                    "ce:indexed-name": "Chotikanokrat P"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "U.",
                                    "@_fa": "true",
                                    "ce:surname": "Permsuwan",
                                    "ce:indexed-name": "Permsuwan U."
                                }
                            ]},
                            "ref-sourcetitle": "Clinicoecon Outcomes Res"
                        },
                        "ce:source-text": "Deerochanawong C, Kosachunhanun N, Gadekar AV, Chotikanokrat P, Permsuwan U. Cost-benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand. Clinicoecon Outcomes Res 2019;11:423-30."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Anderson JE. Combining glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors to target multiple organ defects in type 2 diabetes. Diabetes Spectr 2020;33:165-74.",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Combining glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors to target multiple organ defects in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85091537324",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "165",
                                    "@last": "174"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "JE.",
                                "@_fa": "true",
                                "ce:surname": "Anderson",
                                "ce:indexed-name": "Anderson JE."
                            }]},
                            "ref-sourcetitle": "Diabetes Spectr"
                        },
                        "ce:source-text": "Anderson JE. Combining glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors to target multiple organ defects in type 2 diabetes. Diabetes Spectr 2020;33:165-74."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015;373:2117-28.",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84944800184",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "373"},
                                "pagerange": {
                                    "@first": "2117",
                                    "@last": "2128"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Zinman",
                                        "ce:indexed-name": "Zinman B"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Wanner",
                                        "ce:indexed-name": "Wanner C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Lachin",
                                        "ce:indexed-name": "Lachin JM"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Fitchett",
                                        "ce:indexed-name": "Fitchett D"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Bluhmki",
                                        "ce:indexed-name": "Bluhmki E"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Hantel",
                                        "ce:indexed-name": "Hantel S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015;373:2117-28."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Wanner C, Lachin JM, Inzucchi SE, Fitchett D, Mattheus M, George J, et al. Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease. Circulation 2018;137:119-29.",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85042792101",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "137"},
                                "pagerange": {
                                    "@first": "119",
                                    "@last": "129"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Wanner",
                                        "ce:indexed-name": "Wanner C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Lachin",
                                        "ce:indexed-name": "Lachin JM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SE",
                                        "@_fa": "true",
                                        "ce:surname": "Inzucchi",
                                        "ce:indexed-name": "Inzucchi SE"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Fitchett",
                                        "ce:indexed-name": "Fitchett D"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Mattheus",
                                        "ce:indexed-name": "Mattheus M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "George",
                                        "ce:indexed-name": "George J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "Wanner C, Lachin JM, Inzucchi SE, Fitchett D, Mattheus M, George J, et al. Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease. Circulation 2018;137:119-29."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kaku K, Lee J, Mattheus M, Kaspers S, George J, Woerle HJ. Empagliflozin and cardiovascular outcomes in asian patients with type 2 diabetes and established cardiovascular disease-results from EMPA-REG OUTCOME(®). Circ J 2017;81:227-34.",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Empagliflozin and cardiovascular outcomes in asian patients with type 2 diabetes and established cardiovascular disease-results from EMPA-REG OUTCOME(®)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85010749154",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "81"},
                                "pagerange": {
                                    "@first": "227",
                                    "@last": "234"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Kaku",
                                    "ce:indexed-name": "Kaku K"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Mattheus",
                                    "ce:indexed-name": "Mattheus M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Kaspers",
                                    "ce:indexed-name": "Kaspers S"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "George",
                                    "ce:indexed-name": "George J"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "HJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Woerle",
                                    "ce:indexed-name": "Woerle HJ."
                                }
                            ]},
                            "ref-sourcetitle": "Circ J"
                        },
                        "ce:source-text": "Kaku K, Lee J, Mattheus M, Kaspers S, George J, Woerle HJ. Empagliflozin and cardiovascular outcomes in asian patients with type 2 diabetes and established cardiovascular disease-results from EMPA-REG OUTCOME(®). Circ J 2017;81:227-34."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Mahaffey KW, Neal B, Perkovic V, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin Cardiovascular Assessment Study). Circulation 2018;137:323-34.",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin Cardiovascular Assessment Study)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85048449544",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "137"},
                                "pagerange": {
                                    "@first": "323",
                                    "@last": "334"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "KW",
                                        "@_fa": "true",
                                        "ce:surname": "Mahaffey",
                                        "ce:indexed-name": "Mahaffey KW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Neal",
                                        "ce:indexed-name": "Neal B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Perkovic",
                                        "ce:indexed-name": "Perkovic V"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "de Zeeuw",
                                        "ce:indexed-name": "de Zeeuw D"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Fulcher",
                                        "ce:indexed-name": "Fulcher G"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Erondu",
                                        "ce:indexed-name": "Erondu N"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "Mahaffey KW, Neal B, Perkovic V, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin Cardiovascular Assessment Study). Circulation 2018;137:323-34."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 2017;377:644-57.",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Canagliflozin and cardiovascular and renal events in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85034766786",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "377"},
                                "pagerange": {
                                    "@first": "644",
                                    "@last": "657"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Neal",
                                        "ce:indexed-name": "Neal B"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Perkovic",
                                        "ce:indexed-name": "Perkovic V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "KW",
                                        "@_fa": "true",
                                        "ce:surname": "Mahaffey",
                                        "ce:indexed-name": "Mahaffey KW"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "de Zeeuw",
                                        "ce:indexed-name": "de Zeeuw D"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Fulcher",
                                        "ce:indexed-name": "Fulcher G"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Erondu",
                                        "ce:indexed-name": "Erondu N"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 2017;377:644-57."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, et al. Cardiovascular outcomes with ertugliflozin in type 2 diabetes. N Engl J Med 2020;383:1425-35.",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Cardiovascular outcomes with ertugliflozin in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85092567433",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "383"},
                                "pagerange": {
                                    "@first": "1425",
                                    "@last": "1435"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CP",
                                        "@_fa": "true",
                                        "ce:surname": "Cannon",
                                        "ce:indexed-name": "Cannon CP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Pratley",
                                        "ce:indexed-name": "Pratley R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Dagogo-Jack",
                                        "ce:indexed-name": "Dagogo-Jack S"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Mancuso",
                                        "ce:indexed-name": "Mancuso J"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Huyck",
                                        "ce:indexed-name": "Huyck S"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "U",
                                        "@_fa": "true",
                                        "ce:surname": "Masiukiewicz",
                                        "ce:indexed-name": "Masiukiewicz U"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, et al. Cardiovascular outcomes with ertugliflozin in type 2 diabetes. N Engl J Med 2020;383:1425-35."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "McGuire DK, Shih WJ, Cosentino F, Charbonnel B, Cherney DZI, Dagogo-Jack S, et al. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: A metaanalysis. JAMA Cardiol 2021;6:148-58.",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: A metaanalysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85093966041",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {
                                    "@first": "148",
                                    "@last": "158"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DK",
                                        "@_fa": "true",
                                        "ce:surname": "McGuire",
                                        "ce:indexed-name": "McGuire DK"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Shih",
                                        "ce:indexed-name": "Shih WJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Cosentino",
                                        "ce:indexed-name": "Cosentino F"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Charbonnel",
                                        "ce:indexed-name": "Charbonnel B"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "DZI",
                                        "@_fa": "true",
                                        "ce:surname": "Cherney",
                                        "ce:indexed-name": "Cherney DZI"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Dagogo-Jack",
                                        "ce:indexed-name": "Dagogo-Jack S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA Cardiol"
                        },
                        "ce:source-text": "McGuire DK, Shih WJ, Cosentino F, Charbonnel B, Cherney DZI, Dagogo-Jack S, et al. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: A metaanalysis. JAMA Cardiol 2021;6:148-58."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ghosal S, Sinha B. SGLT-2i and cardiovascular outcomes: A meta-Analysis of The Asian Cohort. J Endocrinol Diab 2018;5:1-2.",
                        "@id": "58",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "SGLT-2i and cardiovascular outcomes: A meta-Analysis of The Asian Cohort"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85085296339",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "2"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Ghosal",
                                    "ce:indexed-name": "Ghosal S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Sinha",
                                    "ce:indexed-name": "Sinha B."
                                }
                            ]},
                            "ref-sourcetitle": "J Endocrinol Diab"
                        },
                        "ce:source-text": "Ghosal S, Sinha B. SGLT-2i and cardiovascular outcomes: A meta-Analysis of The Asian Cohort. J Endocrinol Diab 2018;5:1-2."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, et al. Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucoselowering drugs: The CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors). Circulation 2017;136:249-59.",
                        "@id": "59",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucoselowering drugs: The CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85019731757",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "136"},
                                "pagerange": {
                                    "@first": "249",
                                    "@last": "259"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Kosiborod",
                                        "ce:indexed-name": "Kosiborod M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MA",
                                        "@_fa": "true",
                                        "ce:surname": "Cavender",
                                        "ce:indexed-name": "Cavender MA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AZ",
                                        "@_fa": "true",
                                        "ce:surname": "Fu",
                                        "ce:indexed-name": "Fu AZ"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "JP",
                                        "@_fa": "true",
                                        "ce:surname": "Wilding",
                                        "ce:indexed-name": "Wilding JP"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Khunti",
                                        "ce:indexed-name": "Khunti K"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "RW",
                                        "@_fa": "true",
                                        "ce:surname": "Holl",
                                        "ce:indexed-name": "Holl RW"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, et al. Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucoselowering drugs: The CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors). Circulation 2017;136:249-59."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kosiborod M, Lam CSP, Kohsaka S, Kim DJ, Karasik A, Shaw J, et al. Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: The CVD-REAL 2 study. J Am Coll Cardiol 2018;71:2628-39.",
                        "@id": "60",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: The CVD-REAL 2 study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85047499725",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "71"},
                                "pagerange": {
                                    "@first": "2628",
                                    "@last": "2639"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Kosiborod",
                                        "ce:indexed-name": "Kosiborod M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CSP",
                                        "@_fa": "true",
                                        "ce:surname": "Lam",
                                        "ce:indexed-name": "Lam CSP"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Kohsaka",
                                        "ce:indexed-name": "Kohsaka S"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "DJ",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim DJ"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Karasik",
                                        "ce:indexed-name": "Karasik A"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Shaw",
                                        "ce:indexed-name": "Shaw J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Am Coll Cardiol"
                        },
                        "ce:source-text": "Kosiborod M, Lam CSP, Kohsaka S, Kim DJ, Karasik A, Shaw J, et al. Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: The CVD-REAL 2 study. J Am Coll Cardiol 2018;71:2628-39."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Norhammar A, Bodegard J, Nyström T, Thuresson M, Nathanson D, Eriksson JW. Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study. Diabetes Obes Metab 2019;21:1136-45.",
                        "@id": "61",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85061184387",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "1136",
                                    "@last": "1145"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Norhammar",
                                    "ce:indexed-name": "Norhammar A"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Bodegard",
                                    "ce:indexed-name": "Bodegard J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Nyström",
                                    "ce:indexed-name": "Nystrom T"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Thuresson",
                                    "ce:indexed-name": "Thuresson M"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Nathanson",
                                    "ce:indexed-name": "Nathanson D"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "JW.",
                                    "@_fa": "true",
                                    "ce:surname": "Eriksson",
                                    "ce:indexed-name": "Eriksson JW."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Obes Metab"
                        },
                        "ce:source-text": "Norhammar A, Bodegard J, Nyström T, Thuresson M, Nathanson D, Eriksson JW. Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study. Diabetes Obes Metab 2019;21:1136-45."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2016;375:311-22.",
                        "@id": "62",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Liraglutide and cardiovascular outcomes in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84978839381",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "375"},
                                "pagerange": {
                                    "@first": "311",
                                    "@last": "322"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SP",
                                        "@_fa": "true",
                                        "ce:surname": "Marso",
                                        "ce:indexed-name": "Marso SP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "GH",
                                        "@_fa": "true",
                                        "ce:surname": "Daniels",
                                        "ce:indexed-name": "Daniels GH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Brown-Frandsen",
                                        "ce:indexed-name": "Brown-Frandsen K"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Kristensen",
                                        "ce:indexed-name": "Kristensen P"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Mann",
                                        "ce:indexed-name": "Mann JF"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "MA",
                                        "@_fa": "true",
                                        "ce:surname": "Nauck",
                                        "ce:indexed-name": "Nauck MA"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2016;375:311-22."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 2016;375:1834-44.",
                        "@id": "63",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Semaglutide and cardiovascular outcomes in patients with type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84994813253",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "375"},
                                "pagerange": {
                                    "@first": "1834",
                                    "@last": "1844"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SP",
                                        "@_fa": "true",
                                        "ce:surname": "Marso",
                                        "ce:indexed-name": "Marso SP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SC",
                                        "@_fa": "true",
                                        "ce:surname": "Bain",
                                        "ce:indexed-name": "Bain SC"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Consoli",
                                        "ce:indexed-name": "Consoli A"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "FG",
                                        "@_fa": "true",
                                        "ce:surname": "Eliaschewitz",
                                        "ce:indexed-name": "Eliaschewitz FG"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Jódar",
                                        "ce:indexed-name": "Jodar E"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "LA",
                                        "@_fa": "true",
                                        "ce:surname": "Leiter",
                                        "ce:indexed-name": "Leiter LA"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 2016;375:1834-44."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, et al. Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 2019;381:841-51.",
                        "@id": "64",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85068754660",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "381"},
                                "pagerange": {
                                    "@first": "841",
                                    "@last": "851"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Husain",
                                        "ce:indexed-name": "Husain M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "AL",
                                        "@_fa": "true",
                                        "ce:surname": "Birkenfeld",
                                        "ce:indexed-name": "Birkenfeld AL"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Donsmark",
                                        "ce:indexed-name": "Donsmark M"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Dungan",
                                        "ce:indexed-name": "Dungan K"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "FG",
                                        "@_fa": "true",
                                        "ce:surname": "Eliaschewitz",
                                        "ce:indexed-name": "Eliaschewitz FG"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "DR",
                                        "@_fa": "true",
                                        "ce:surname": "Franco",
                                        "ce:indexed-name": "Franco DR"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, et al. Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 2019;381:841-51."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hernandez AF, Green JB, Janmohamed S, D Agostino RB, Sr., Granger CB, Jones NP, et al. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebocontrolled trial. Lancet 2018;392:1519-29.",
                        "@id": "65",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebocontrolled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85055101508",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "392"},
                                "pagerange": {
                                    "@first": "1519",
                                    "@last": "1529"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AF",
                                        "@_fa": "true",
                                        "ce:surname": "Hernandez",
                                        "ce:indexed-name": "Hernandez AF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JB",
                                        "@_fa": "true",
                                        "ce:surname": "Green",
                                        "ce:indexed-name": "Green JB"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Janmohamed",
                                        "ce:indexed-name": "Janmohamed S"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "RB",
                                        "@_fa": "true",
                                        "ce:surname": "D Agostino",
                                        "ce:indexed-name": "D Agostino RB"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "CB",
                                        "@_fa": "true",
                                        "ce:surname": "Granger",
                                        "ce:indexed-name": "Granger CB"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "NP",
                                        "@_fa": "true",
                                        "ce:surname": "Jones",
                                        "ce:indexed-name": "Jones NP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Hernandez AF, Green JB, Janmohamed S, D Agostino RB, Sr., Granger CB, Jones NP, et al. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebocontrolled trial. Lancet 2018;392:1519-29."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, et al. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med 2015;373:2247-57.",
                        "@id": "66",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Lixisenatide in patients with type 2 diabetes and acute coronary syndrome"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84948740668",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "373"},
                                "pagerange": {
                                    "@first": "2247",
                                    "@last": "2257"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MA",
                                        "@_fa": "true",
                                        "ce:surname": "Pfeffer",
                                        "ce:indexed-name": "Pfeffer MA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Claggett",
                                        "ce:indexed-name": "Claggett B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Diaz",
                                        "ce:indexed-name": "Diaz R"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Dickstein",
                                        "ce:indexed-name": "Dickstein K"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "HC",
                                        "@_fa": "true",
                                        "ce:surname": "Gerstein",
                                        "ce:indexed-name": "Gerstein HC"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "LV",
                                        "@_fa": "true",
                                        "ce:surname": "Køber",
                                        "ce:indexed-name": "Kober LV"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, et al. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med 2015;373:2247-57."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, et al. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes. N Engl J Med 2017;377:1228-39.",
                        "@id": "67",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85030448557",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "377"},
                                "pagerange": {
                                    "@first": "1228",
                                    "@last": "1239"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RR",
                                        "@_fa": "true",
                                        "ce:surname": "Holman",
                                        "ce:indexed-name": "Holman RR"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MA",
                                        "@_fa": "true",
                                        "ce:surname": "Bethel",
                                        "ce:indexed-name": "Bethel MA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "RJ",
                                        "@_fa": "true",
                                        "ce:surname": "Mentz",
                                        "ce:indexed-name": "Mentz RJ"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "VP",
                                        "@_fa": "true",
                                        "ce:surname": "Thompson",
                                        "ce:indexed-name": "Thompson VP"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Lokhnygina",
                                        "ce:indexed-name": "Lokhnygina Y"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "JB",
                                        "@_fa": "true",
                                        "ce:surname": "Buse",
                                        "ce:indexed-name": "Buse JB"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, et al. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes. N Engl J Med 2017;377:1228-39."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebocontrolled trial. Lancet 2019;394:121-30.",
                        "@id": "68",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebocontrolled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85068151338",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "394"},
                                "pagerange": {
                                    "@first": "121",
                                    "@last": "130"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HC",
                                        "@_fa": "true",
                                        "ce:surname": "Gerstein",
                                        "ce:indexed-name": "Gerstein HC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "HM",
                                        "@_fa": "true",
                                        "ce:surname": "Colhoun",
                                        "ce:indexed-name": "Colhoun HM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GR",
                                        "@_fa": "true",
                                        "ce:surname": "Dagenais",
                                        "ce:indexed-name": "Dagenais GR"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Diaz",
                                        "ce:indexed-name": "Diaz R"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lakshmanan",
                                        "ce:indexed-name": "Lakshmanan M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Pais",
                                        "ce:indexed-name": "Pais P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebocontrolled trial. Lancet 2019;394:121-30."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Furtado RHM, et al. Comparison of the effects of glucagon-like peptide receptor agonists and sodiumglucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus. Circulation 2019;139:2022-31.",
                        "@id": "69",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Comparison of the effects of glucagon-like peptide receptor agonists and sodiumglucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85065306608",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "139"},
                                "pagerange": {
                                    "@first": "2022",
                                    "@last": "2031"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "TA",
                                        "@_fa": "true",
                                        "ce:surname": "Zelniker",
                                        "ce:indexed-name": "Zelniker TA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SD",
                                        "@_fa": "true",
                                        "ce:surname": "Wiviott",
                                        "ce:indexed-name": "Wiviott SD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Raz",
                                        "ce:indexed-name": "Raz I"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im K"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "EL",
                                        "@_fa": "true",
                                        "ce:surname": "Goodrich",
                                        "ce:indexed-name": "Goodrich EL"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "RHM",
                                        "@_fa": "true",
                                        "ce:surname": "Furtado",
                                        "ce:indexed-name": "Furtado RHM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Furtado RHM, et al. Comparison of the effects of glucagon-like peptide receptor agonists and sodiumglucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus. Circulation 2019;139:2022-31."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kang YM, Cho YK, Lee J, Lee SE, Lee WJ, Park JY, et al. Asian subpopulations may exhibit greater cardiovascular benefit from long-Acting glucagonlike peptide 1 receptor agonists: A meta-Analysis of cardiovascular outcome trials. Diabetes Metab J 2019;43:410-21.",
                        "@id": "70",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Asian subpopulations may exhibit greater cardiovascular benefit from long-Acting glucagonlike peptide 1 receptor agonists: A meta-Analysis of cardiovascular outcome trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85072115754",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "43"},
                                "pagerange": {
                                    "@first": "410",
                                    "@last": "421"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "YM",
                                        "@_fa": "true",
                                        "ce:surname": "Kang",
                                        "ce:indexed-name": "Kang YM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "YK",
                                        "@_fa": "true",
                                        "ce:surname": "Cho",
                                        "ce:indexed-name": "Cho YK"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee J"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "SE",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee SE"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee WJ"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "JY",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park JY"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Metab J"
                        },
                        "ce:source-text": "Kang YM, Cho YK, Lee J, Lee SE, Lee WJ, Park JY, et al. Asian subpopulations may exhibit greater cardiovascular benefit from long-Acting glucagonlike peptide 1 receptor agonists: A meta-Analysis of cardiovascular outcome trials. Diabetes Metab J 2019;43:410-21."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "McMurray JJV, Wheeler DC, Stefánsson BV, Jongs N, Postmus D, Correa-Rotter R, et al. Effect of dapagliflozin on clinical outcomes in patients with chronic kidney disease, with and without cardiovascular disease. Circulation 2021;143:438-48.",
                        "@id": "71",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Effect of dapagliflozin on clinical outcomes in patients with chronic kidney disease, with and without cardiovascular disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85102090634",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "143"},
                                "pagerange": {
                                    "@first": "438",
                                    "@last": "448"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JJV",
                                        "@_fa": "true",
                                        "ce:surname": "McMurray",
                                        "ce:indexed-name": "McMurray JJV"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DC",
                                        "@_fa": "true",
                                        "ce:surname": "Wheeler",
                                        "ce:indexed-name": "Wheeler DC"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "BV",
                                        "@_fa": "true",
                                        "ce:surname": "Stefánsson",
                                        "ce:indexed-name": "Stefansson BV"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Jongs",
                                        "ce:indexed-name": "Jongs N"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Postmus",
                                        "ce:indexed-name": "Postmus D"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Correa-Rotter",
                                        "ce:indexed-name": "Correa-Rotter R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "McMurray JJV, Wheeler DC, Stefánsson BV, Jongs N, Postmus D, Correa-Rotter R, et al. Effect of dapagliflozin on clinical outcomes in patients with chronic kidney disease, with and without cardiovascular disease. Circulation 2021;143:438-48."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 2016;375:323-34.",
                        "@id": "72",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Empagliflozin and progression of kidney disease in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84979895487",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "375"},
                                "pagerange": {
                                    "@first": "323",
                                    "@last": "334"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Wanner",
                                        "ce:indexed-name": "Wanner C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SE",
                                        "@_fa": "true",
                                        "ce:surname": "Inzucchi",
                                        "ce:indexed-name": "Inzucchi SE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Lachin",
                                        "ce:indexed-name": "Lachin JM"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Fitchett",
                                        "ce:indexed-name": "Fitchett D"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "von Eynatten",
                                        "ce:indexed-name": "von Eynatten M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Mattheus",
                                        "ce:indexed-name": "Mattheus M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 2016;375:323-34."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kadowaki T, Nangaku M, Hantel S, Okamura T, von Eynatten M, Wanner C, et al. Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA-REG OUTCOME(®) trial. J Diabetes Investig 2019;10:760-70.",
                        "@id": "73",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA-REG OUTCOME(®) trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85059610198",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "760",
                                    "@last": "770"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Kadowaki",
                                        "ce:indexed-name": "Kadowaki T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Nangaku",
                                        "ce:indexed-name": "Nangaku M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Hantel",
                                        "ce:indexed-name": "Hantel S"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Okamura",
                                        "ce:indexed-name": "Okamura T"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "von Eynatten",
                                        "ce:indexed-name": "von Eynatten M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Wanner",
                                        "ce:indexed-name": "Wanner C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Diabetes Investig"
                        },
                        "ce:source-text": "Kadowaki T, Nangaku M, Hantel S, Okamura T, von Eynatten M, Wanner C, et al. Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA-REG OUTCOME(®) trial. J Diabetes Investig 2019;10:760-70."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Neuen BL, Ohkuma T, Neal B, Matthews DR, de Zeeuw D, Mahaffey KW, et al. Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function. Circulation 2018;138:1537-50.",
                        "@id": "74",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85053770094",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "138"},
                                "pagerange": {
                                    "@first": "1537",
                                    "@last": "1550"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BL",
                                        "@_fa": "true",
                                        "ce:surname": "Neuen",
                                        "ce:indexed-name": "Neuen BL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Ohkuma",
                                        "ce:indexed-name": "Ohkuma T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Neal",
                                        "ce:indexed-name": "Neal B"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "DR",
                                        "@_fa": "true",
                                        "ce:surname": "Matthews",
                                        "ce:indexed-name": "Matthews DR"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "de Zeeuw",
                                        "ce:indexed-name": "de Zeeuw D"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "KW",
                                        "@_fa": "true",
                                        "ce:surname": "Mahaffey",
                                        "ce:indexed-name": "Mahaffey KW"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "Neuen BL, Ohkuma T, Neal B, Matthews DR, de Zeeuw D, Mahaffey KW, et al. Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function. Circulation 2018;138:1537-50."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Mosenzon O, Wiviott SD, Cahn A, Rozenberg A, Yanuv I, Goodrich EL, et al. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: An analysis from the DECLARE-TIMI 58 randomised trial. Lancet Diabetes Endocrinol 2019;7:606-17.",
                        "@id": "75",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: An analysis from the DECLARE-TIMI 58 randomised trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85067060766",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "606",
                                    "@last": "617"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "O",
                                        "@_fa": "true",
                                        "ce:surname": "Mosenzon",
                                        "ce:indexed-name": "Mosenzon O"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SD",
                                        "@_fa": "true",
                                        "ce:surname": "Wiviott",
                                        "ce:indexed-name": "Wiviott SD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Cahn",
                                        "ce:indexed-name": "Cahn A"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Rozenberg",
                                        "ce:indexed-name": "Rozenberg A"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Yanuv",
                                        "ce:indexed-name": "Yanuv I"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "EL",
                                        "@_fa": "true",
                                        "ce:surname": "Goodrich",
                                        "ce:indexed-name": "Goodrich EL"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Diabetes Endocrinol"
                        },
                        "ce:source-text": "Mosenzon O, Wiviott SD, Cahn A, Rozenberg A, Yanuv I, Goodrich EL, et al. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: An analysis from the DECLARE-TIMI 58 randomised trial. Lancet Diabetes Endocrinol 2019;7:606-17."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Seidu S, Kunutsor SK, Cos X, Gillani S, Khunti K. SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-Analysis. Prim Care Diabetes 2018;12:265-83.",
                        "@id": "76",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-Analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85042441341",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "265",
                                    "@last": "283"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Seidu",
                                    "ce:indexed-name": "Seidu S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "SK",
                                    "@_fa": "true",
                                    "ce:surname": "Kunutsor",
                                    "ce:indexed-name": "Kunutsor SK"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "X",
                                    "@_fa": "true",
                                    "ce:surname": "Cos",
                                    "ce:indexed-name": "Cos X"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Gillani",
                                    "ce:indexed-name": "Gillani S"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Khunti",
                                    "ce:indexed-name": "Khunti K."
                                }
                            ]},
                            "ref-sourcetitle": "Prim Care Diabetes"
                        },
                        "ce:source-text": "Seidu S, Kunutsor SK, Cos X, Gillani S, Khunti K. SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-Analysis. Prim Care Diabetes 2018;12:265-83."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kelly MS, Lewis J, Huntsberry AM, Dea L, Portillo I. Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease. Postgrad Med 2019;131:31-42.",
                        "@id": "77",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85057526104",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "131"},
                                "pagerange": {
                                    "@first": "31",
                                    "@last": "42"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "MS",
                                    "@_fa": "true",
                                    "ce:surname": "Kelly",
                                    "ce:indexed-name": "Kelly MS"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Lewis",
                                    "ce:indexed-name": "Lewis J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "AM",
                                    "@_fa": "true",
                                    "ce:surname": "Huntsberry",
                                    "ce:indexed-name": "Huntsberry AM"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Dea",
                                    "ce:indexed-name": "Dea L"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Portillo",
                                    "ce:indexed-name": "Portillo I."
                                }
                            ]},
                            "ref-sourcetitle": "Postgrad Med"
                        },
                        "ce:source-text": "Kelly MS, Lewis J, Huntsberry AM, Dea L, Portillo I. Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease. Postgrad Med 2019;131:31-42."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Heerspink HJL, Karasik A, Thuresson M, Melzer-Cohen C, Chodick G, Khunti K, et al. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): A multinational observational cohort study. Lancet Diabetes Endocrinol 2020;8:27-35.",
                        "@id": "78",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): A multinational observational cohort study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85076615525",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "27",
                                    "@last": "35"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HJL",
                                        "@_fa": "true",
                                        "ce:surname": "Heerspink",
                                        "ce:indexed-name": "Heerspink HJL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Karasik",
                                        "ce:indexed-name": "Karasik A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Thuresson",
                                        "ce:indexed-name": "Thuresson M"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Melzer-Cohen",
                                        "ce:indexed-name": "Melzer-Cohen C"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Chodick",
                                        "ce:indexed-name": "Chodick G"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Khunti",
                                        "ce:indexed-name": "Khunti K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Diabetes Endocrinol"
                        },
                        "ce:source-text": "Heerspink HJL, Karasik A, Thuresson M, Melzer-Cohen C, Chodick G, Khunti K, et al. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): A multinational observational cohort study. Lancet Diabetes Endocrinol 2020;8:27-35."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, et al. Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med 2017;377:839-48.",
                        "@id": "79",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Liraglutide and renal outcomes in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85028547742",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "377"},
                                "pagerange": {
                                    "@first": "839",
                                    "@last": "848"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JFE",
                                        "@_fa": "true",
                                        "ce:surname": "Mann",
                                        "ce:indexed-name": "Mann JFE"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DD",
                                        "@_fa": "true",
                                        "ce:surname": "Ørsted",
                                        "ce:indexed-name": "Orsted DD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Brown-Frandsen",
                                        "ce:indexed-name": "Brown-Frandsen K"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "SP",
                                        "@_fa": "true",
                                        "ce:surname": "Marso",
                                        "ce:indexed-name": "Marso SP"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "NR",
                                        "@_fa": "true",
                                        "ce:surname": "Poulter",
                                        "ce:indexed-name": "Poulter NR"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Rasmussen",
                                        "ce:indexed-name": "Rasmussen S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, et al. Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med 2017;377:839-48."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and renal outcomes in type 2 diabetes: An exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet 2019;394:131-8.",
                        "@id": "80",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Dulaglutide and renal outcomes in type 2 diabetes: An exploratory analysis of the REWIND randomised, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85068568021",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "394"},
                                "pagerange": {
                                    "@first": "131",
                                    "@last": "138"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "HC",
                                        "@_fa": "true",
                                        "ce:surname": "Gerstein",
                                        "ce:indexed-name": "Gerstein HC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "HM",
                                        "@_fa": "true",
                                        "ce:surname": "Colhoun",
                                        "ce:indexed-name": "Colhoun HM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GR",
                                        "@_fa": "true",
                                        "ce:surname": "Dagenais",
                                        "ce:indexed-name": "Dagenais GR"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Diaz",
                                        "ce:indexed-name": "Diaz R"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lakshmanan",
                                        "ce:indexed-name": "Lakshmanan M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Pais",
                                        "ce:indexed-name": "Pais P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and renal outcomes in type 2 diabetes: An exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet 2019;394:131-8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Muskiet MHA, Tonneijck L, Huang Y, Liu M, Saremi A, Heerspink HJL, et al. Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: An exploratory analysis of the ELIXA randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 2018;6:859-69.",
                        "@id": "81",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: An exploratory analysis of the ELIXA randomised, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85055612603",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {
                                    "@first": "859",
                                    "@last": "869"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MHA",
                                        "@_fa": "true",
                                        "ce:surname": "Muskiet",
                                        "ce:indexed-name": "Muskiet MHA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Tonneijck",
                                        "ce:indexed-name": "Tonneijck L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang Y"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu M"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Saremi",
                                        "ce:indexed-name": "Saremi A"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "HJL",
                                        "@_fa": "true",
                                        "ce:surname": "Heerspink",
                                        "ce:indexed-name": "Heerspink HJL"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Diabetes Endocrinol"
                        },
                        "ce:source-text": "Muskiet MHA, Tonneijck L, Huang Y, Liu M, Saremi A, Heerspink HJL, et al. Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: An exploratory analysis of the ELIXA randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 2018;6:859-69."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bethel MA, Mentz RJ, Merrill P, Buse JB, Chan JC, Goodman SG, et al. Renal outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). Diabetes 2018;67 Suppl 1:522-P.",
                        "@id": "82",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Renal outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85062440759",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {"@first": "522"}
                            },
                            "ref-text": "Suppl 1:-P",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MA",
                                        "@_fa": "true",
                                        "ce:surname": "Bethel",
                                        "ce:indexed-name": "Bethel MA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RJ",
                                        "@_fa": "true",
                                        "ce:surname": "Mentz",
                                        "ce:indexed-name": "Mentz RJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Merrill",
                                        "ce:indexed-name": "Merrill P"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "JB",
                                        "@_fa": "true",
                                        "ce:surname": "Buse",
                                        "ce:indexed-name": "Buse JB"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "JC",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan JC"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "SG",
                                        "@_fa": "true",
                                        "ce:surname": "Goodman",
                                        "ce:indexed-name": "Goodman SG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes"
                        },
                        "ce:source-text": "Bethel MA, Mentz RJ, Merrill P, Buse JB, Chan JC, Goodman SG, et al. Renal outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). Diabetes 2018;67 Suppl 1:522-P."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, et al. Sotagliflozin in patients with diabetes and chronic kidney disease. N Engl J Med 2021;384:129-39.",
                        "@id": "83",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Sotagliflozin in patients with diabetes and chronic kidney disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85099718366",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "384"},
                                "pagerange": {
                                    "@first": "129",
                                    "@last": "139"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DL",
                                        "@_fa": "true",
                                        "ce:surname": "Bhatt",
                                        "ce:indexed-name": "Bhatt DL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Szarek",
                                        "ce:indexed-name": "Szarek M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Pitt",
                                        "ce:indexed-name": "Pitt B"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "CP",
                                        "@_fa": "true",
                                        "ce:surname": "Cannon",
                                        "ce:indexed-name": "Cannon CP"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "LA",
                                        "@_fa": "true",
                                        "ce:surname": "Leiter",
                                        "ce:indexed-name": "Leiter LA"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "DK",
                                        "@_fa": "true",
                                        "ce:surname": "McGuire",
                                        "ce:indexed-name": "McGuire DK"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, et al. Sotagliflozin in patients with diabetes and chronic kidney disease. N Engl J Med 2021;384:129-39."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bhatt DL, Szarek M, Steg PG, Cannon CP, Leiter LA, McGuire DK, et al. Sotagliflozin in patients with diabetes and recent worsening heart failure. N Engl J Med 2021;384:117-28.",
                        "@id": "84",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Sotagliflozin in patients with diabetes and recent worsening heart failure"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85099764927",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "384"},
                                "pagerange": {
                                    "@first": "117",
                                    "@last": "128"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DL",
                                        "@_fa": "true",
                                        "ce:surname": "Bhatt",
                                        "ce:indexed-name": "Bhatt DL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Szarek",
                                        "ce:indexed-name": "Szarek M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "PG",
                                        "@_fa": "true",
                                        "ce:surname": "Steg",
                                        "ce:indexed-name": "Steg PG"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "CP",
                                        "@_fa": "true",
                                        "ce:surname": "Cannon",
                                        "ce:indexed-name": "Cannon CP"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "LA",
                                        "@_fa": "true",
                                        "ce:surname": "Leiter",
                                        "ce:indexed-name": "Leiter LA"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "DK",
                                        "@_fa": "true",
                                        "ce:surname": "McGuire",
                                        "ce:indexed-name": "McGuire DK"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Bhatt DL, Szarek M, Steg PG, Cannon CP, Leiter LA, McGuire DK, et al. Sotagliflozin in patients with diabetes and recent worsening heart failure. N Engl J Med 2021;384:117-28."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019;381:1995-2008.",
                        "@id": "85",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Dapagliflozin in patients with heart failure and reduced ejection fraction"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85073118508",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "381"},
                                "pagerange": {
                                    "@first": "1995",
                                    "@last": "2008"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JJV",
                                        "@_fa": "true",
                                        "ce:surname": "McMurray",
                                        "ce:indexed-name": "McMurray JJV"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SD",
                                        "@_fa": "true",
                                        "ce:surname": "Solomon",
                                        "ce:indexed-name": "Solomon SD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SE",
                                        "@_fa": "true",
                                        "ce:surname": "Inzucchi",
                                        "ce:indexed-name": "Inzucchi SE"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Køber",
                                        "ce:indexed-name": "Kober L"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "MN",
                                        "@_fa": "true",
                                        "ce:surname": "Kosiborod",
                                        "ce:indexed-name": "Kosiborod MN"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "FA",
                                        "@_fa": "true",
                                        "ce:surname": "Martinez",
                                        "ce:indexed-name": "Martinez FA"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019;381:1995-2008."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 2020;383:1413-24.",
                        "@id": "86",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Cardiovascular and renal outcomes with empagliflozin in heart failure"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85090992310",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "383"},
                                "pagerange": {
                                    "@first": "1413",
                                    "@last": "1424"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Packer",
                                        "ce:indexed-name": "Packer M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SD",
                                        "@_fa": "true",
                                        "ce:surname": "Anker",
                                        "ce:indexed-name": "Anker SD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Butler",
                                        "ce:indexed-name": "Butler J"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Filippatos",
                                        "ce:indexed-name": "Filippatos G"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "SJ",
                                        "@_fa": "true",
                                        "ce:surname": "Pocock",
                                        "ce:indexed-name": "Pocock SJ"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Carson",
                                        "ce:indexed-name": "Carson P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 2020;383:1413-24."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. Circulation 2013;128:e240-327.",
                        "@id": "87",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84885845957",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "128"},
                                "pagerange": {
                                    "@first": "e240",
                                    "@last": "e327"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CW",
                                        "@_fa": "true",
                                        "ce:surname": "Yancy",
                                        "ce:indexed-name": "Yancy CW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Jessup",
                                        "ce:indexed-name": "Jessup M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Bozkurt",
                                        "ce:indexed-name": "Bozkurt B"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Butler",
                                        "ce:indexed-name": "Butler J"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "DE",
                                        "@_fa": "true",
                                        "ce:surname": "Casey",
                                        "ce:indexed-name": "Casey DE"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "MH",
                                        "@_fa": "true",
                                        "ce:surname": "Drazner",
                                        "ce:indexed-name": "Drazner MH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. Circulation 2013;128:e240-327."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 2010;25:1567-75.",
                        "@id": "88",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77951683572",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "1567",
                                    "@last": "1575"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Ingsathit",
                                        "ce:indexed-name": "Ingsathit A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Thakkinstian",
                                        "ce:indexed-name": "Thakkinstian A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Chaiprasert",
                                        "ce:indexed-name": "Chaiprasert A"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Sangthawan",
                                        "ce:indexed-name": "Sangthawan P"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Gojaseni",
                                        "ce:indexed-name": "Gojaseni P"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Kiattisunthorn",
                                        "ce:indexed-name": "Kiattisunthorn K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nephrol Dial Transplant"
                        },
                        "ce:source-text": "Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 2010;25:1567-75."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Satirapoj B, Supasyndh O, Mayteedol N, Chaiprasert A, Choovichian P. Metabolic syndrome and its relation to chronic kidney disease in a Southeast Asian population. Southeast Asian J Trop Med Public Health 2011;42:176-83.",
                        "@id": "89",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Metabolic syndrome and its relation to chronic kidney disease in a Southeast Asian population"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79953741245",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "42"},
                                "pagerange": {
                                    "@first": "176",
                                    "@last": "183"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B",
                                    "@_fa": "true",
                                    "ce:surname": "Satirapoj",
                                    "ce:indexed-name": "Satirapoj B"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "O",
                                    "@_fa": "true",
                                    "ce:surname": "Supasyndh",
                                    "ce:indexed-name": "Supasyndh O"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Mayteedol",
                                    "ce:indexed-name": "Mayteedol N"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Chaiprasert",
                                    "ce:indexed-name": "Chaiprasert A"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Choovichian",
                                    "ce:indexed-name": "Choovichian P."
                                }
                            ]},
                            "ref-sourcetitle": "Southeast Asian J Trop Med Public Health"
                        },
                        "ce:source-text": "Satirapoj B, Supasyndh O, Mayteedol N, Chaiprasert A, Choovichian P. Metabolic syndrome and its relation to chronic kidney disease in a Southeast Asian population. Southeast Asian J Trop Med Public Health 2011;42:176-83."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Satirapoj B, Korkiatpitak P, Supasyndh O. Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: A randomized controlled trial. Clin Kidney J 2019;12:326-32.",
                        "@id": "90",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: A randomized controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85071190343",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "326",
                                    "@last": "332"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B",
                                    "@_fa": "true",
                                    "ce:surname": "Satirapoj",
                                    "ce:indexed-name": "Satirapoj B"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Korkiatpitak",
                                    "ce:indexed-name": "Korkiatpitak P"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Supasyndh",
                                    "ce:indexed-name": "Supasyndh O."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Kidney J"
                        },
                        "ce:source-text": "Satirapoj B, Korkiatpitak P, Supasyndh O. Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: A randomized controlled trial. Clin Kidney J 2019;12:326-32."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85120625176",
        "dc:description": "Background: Cardiovascular (CV) and renal comorbidities are common among type 2 diabetes (T2D) patients, and significantly increase the cost and burden of care. Both sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) improve key outcomes including major CV events, hospitalization for heart failure, and renal outcomes, albeit to varying degrees in different T2D populations. Materials and Methods: The authors reviewed evidence from GLP-1 RA and SGLT2i CV outcomes trials and real-world studies in Thailand and elsewhere. Results: The authors formulated recommendations to guide selection of anti-diabetes medication based on patients clinical characteristics and CV or renal risk profile. Conclusion: These recommendations could help guide management of CV/renal comorbidities and risk alongside glucose-lowering therapy for individual patients.",
        "prism:coverDate": "2021-11-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85120625176",
        "dc:creator": {"author": [{
            "ce:given-name": "Rungroj",
            "preferred-name": {
                "ce:given-name": "Rungroj",
                "ce:initials": "R.",
                "ce:surname": "Krittayaphong",
                "ce:indexed-name": "Krittayaphong R."
            },
            "@seq": "1",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012718",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"
            },
            "ce:degrees": "MD",
            "ce:surname": "Krittayaphong",
            "@auid": "7004257129",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004257129",
            "ce:indexed-name": "Krittayaphong R."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85120625176"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85120625176&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85120625176&origin=inward"
            }
        ],
        "source-id": "17780",
        "citedby-count": "0",
        "prism:volume": "104",
        "subtype": "re",
        "dc:title": "The Use of SGLT2i and GLP-1 RA in patients with type 2 diabetes in thailand: Evidence review and recommendations",
        "openaccess": "0",
        "prism:issn": "01252208",
        "publishercopyright": "© 2021 Medical Association of Thailand. All rights reserved.",
        "prism:issueIdentifier": "11",
        "subtypeDescription": "Review",
        "prism:publicationName": "Journal of the Medical Association of Thailand",
        "prism:pageRange": "1850-1865",
        "prism:endingPage": "1865",
        "openaccessFlag": "false",
        "prism:doi": "10.35755/jmedassocthai.2021.11.13163",
        "prism:startingPage": "1850",
        "dc:identifier": "SCOPUS_ID:85120625176",
        "dc:publisher": "Medical Association of Thailand"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Cardiovascular diseases"
        },
        {
            "@_fa": "true",
            "$": "Chronic kidney disease"
        },
        {
            "@_fa": "true",
            "$": "Clinical outcomes"
        },
        {
            "@_fa": "true",
            "$": "GLP-1 RA"
        },
        {
            "@_fa": "true",
            "$": "SGLT2i"
        },
        {
            "@_fa": "true",
            "$": "Type 2 diabetes mellitus"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Medicine (all)",
        "@code": "2700",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Rungroj",
            "preferred-name": {
                "ce:given-name": "Rungroj",
                "ce:initials": "R.",
                "ce:surname": "Krittayaphong",
                "ce:indexed-name": "Krittayaphong R."
            },
            "@seq": "1",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012718",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"
            },
            "ce:degrees": "MD",
            "ce:surname": "Krittayaphong",
            "@auid": "7004257129",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004257129",
            "ce:indexed-name": "Krittayaphong R."
        },
        {
            "ce:given-name": "Bancha",
            "preferred-name": {
                "ce:given-name": "Bancha",
                "ce:initials": "B.",
                "ce:surname": "Satirapoj",
                "ce:indexed-name": "Satirapoj B."
            },
            "@seq": "2",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006964",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964"
            },
            "ce:degrees": "MD",
            "ce:surname": "Satirapoj",
            "@auid": "14632290200",
            "author-url": "https://api.elsevier.com/content/author/author_id/14632290200",
            "ce:indexed-name": "Satirapoj B."
        },
        {
            "ce:given-name": "Boonsong",
            "preferred-name": {
                "ce:given-name": "Boonsong",
                "ce:initials": "B.",
                "ce:surname": "Ongphiphadhanakul",
                "ce:indexed-name": "Ongphiphadhanakul B."
            },
            "@seq": "3",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012718",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"
            },
            "ce:degrees": "MD",
            "ce:surname": "Ongphiphadhanakul",
            "@auid": "7004840966",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004840966",
            "ce:indexed-name": "Ongphiphadhanakul B."
        },
        {
            "ce:given-name": "Kriengsak",
            "preferred-name": {
                "ce:given-name": "Kriengsak",
                "ce:initials": "K.",
                "ce:surname": "Vareesangthip",
                "ce:indexed-name": "Vareesangthip K."
            },
            "@seq": "4",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012718",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Vareesangthip",
            "@auid": "56871049000",
            "author-url": "https://api.elsevier.com/content/author/author_id/56871049000",
            "ce:indexed-name": "Vareesangthip K."
        },
        {
            "ce:given-name": "Sompongse",
            "preferred-name": {
                "ce:given-name": "Sompongse",
                "ce:initials": "S.",
                "ce:surname": "Suwanwalaikorn",
                "ce:indexed-name": "Suwanwalaikorn S."
            },
            "@seq": "5",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:degrees": "MD",
            "ce:surname": "Suwanwalaikorn",
            "@auid": "6506935197",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506935197",
            "ce:indexed-name": "Suwanwalaikorn S."
        },
        {
            "ce:given-name": "Wacin",
            "preferred-name": {
                "ce:given-name": "Wacin",
                "ce:initials": "W.",
                "ce:surname": "Buddhari",
                "ce:indexed-name": "Buddhari W."
            },
            "@seq": "6",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:degrees": "MD",
            "ce:surname": "Buddhari",
            "@auid": "57192991797",
            "author-url": "https://api.elsevier.com/content/author/author_id/57192991797",
            "ce:indexed-name": "Buddhari W."
        }
    ]}
}}